[{"lang":"en","text":"@EMA_News \nI just send a letter to the EMA about the refusing of the medicine Scenesse for EPP patients.","conversation_id":"333531395681054720","source":"Twitter Web Client","id":"333531395681054720","created_at":"2013-05-12T10:37:36.000Z","possibly_sensitive":false,"author_id":"1367162942","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: We've released a draft revised guideline on #biosimilars for public consultation: http://t.co/usuyVsQF2z”","conversation_id":"332143290981953536","source":"Twitter for iPad","id":"332180177247432704","created_at":"2013-05-08T17:08:20.000Z","possibly_sensitive":false,"author_id":"514255564","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":56,"end":68,"tag":"biosimilars"}],"urls":[{"start":94,"end":116,"url":"http://t.co/usuyVsQF2z","expanded_url":"http://bit.ly/18Y86e9","display_url":"bit.ly/18Y86e9"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"332143290981953536"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News: We've released new recommendations on #phthalates and #parabens in human medicines for public consultation http://t.co/ifhjPheUD7","conversation_id":"332059346139758592","source":"Twitter for iPad","id":"332062820189487104","created_at":"2013-05-08T09:22:00.000Z","possibly_sensitive":false,"author_id":"514255564","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":49,"end":60,"tag":"phthalates"},{"start":65,"end":74,"tag":"parabens"}],"urls":[{"start":118,"end":140,"url":"http://t.co/ifhjPheUD7","expanded_url":"http://bit.ly/16gfxkj","display_url":"bit.ly/16gfxkj"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"332059346139758592"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News thansk for the response! I will look into it. A great way to start the week :-) @EUombudsman","conversation_id":"326643289967190017","source":"Twitter Web Client","id":"331333004792315905","created_at":"2013-05-06T09:01:58.000Z","possibly_sensitive":false,"author_id":"1260521084","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":90,"end":102,"username":"EUombudsman","id":"873777758"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"331323367900729345"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: RT @LV_MPA: Group manager for clinical trials http://t.co/ykP9hPrd7h #newjob”","conversation_id":"330339899066687488","source":"Twitter for iPad","id":"330419344729321472","created_at":"2013-05-03T20:31:25.000Z","possibly_sensitive":false,"author_id":"514255564","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"},{"start":15,"end":22,"username":"LV_MPA","id":"77047226"}],"hashtags":[{"start":81,"end":88,"tag":"newjob"}],"urls":[{"start":58,"end":80,"url":"http://t.co/ykP9hPrd7h","expanded_url":"http://bit.ly/158yd5p","display_url":"bit.ly/158yd5p"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"330339899066687488"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: We have announced first details of  the planned reorganisation of the EMA: http://t.co/VLndLtU39M”","conversation_id":"330249896210857984","source":"Twitter for iPad","id":"330418028149895168","created_at":"2013-05-03T20:26:11.000Z","possibly_sensitive":false,"author_id":"514255564","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":87,"end":109,"url":"http://t.co/VLndLtU39M","expanded_url":"http://bit.ly/ZZxuz7","display_url":"bit.ly/ZZxuz7"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"330249896210857984"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News \nFrom Jim Murray \n@openmedicineeu\nSee my blog for background on the companies taking EMA to court. http://t.co/5J5v2WCbui","conversation_id":"329881954063380480","source":"Twitter Web Client","id":"329881954063380480","created_at":"2013-05-02T08:56:01.000Z","possibly_sensitive":false,"author_id":"217384354","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":28,"end":43,"username":"OpenMedicineEU","id":"217384354"}],"hashtags":{},"urls":[{"start":109,"end":131,"url":"http://t.co/5J5v2WCbui","expanded_url":"http://www.openmedicineeu.blogactiv.eu","display_url":"openmedicineeu.blogactiv.eu"}],"annotations":[{"start":16,"end":25,"probability":0.9795,"type":"Person","normalized_text":"Jim Murray"}],"cashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: EMA publishes final advice from clinical trial advisory groups: http://t.co/75DBS1DiBc” -&gt; data sharing is very doable","conversation_id":"329246171644170241","source":"Twitter for iPad","id":"329261502420889600","created_at":"2013-04-30T15:50:34.000Z","possibly_sensitive":false,"author_id":"16947313","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":76,"end":98,"url":"http://t.co/75DBS1DiBc","expanded_url":"http://bit.ly/ZTNq64","display_url":"bit.ly/ZTNq64"}],"annotations":[{"start":12,"end":14,"probability":0.4178,"type":"Organization","normalized_text":"EMA"}],"cashtags":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"329246171644170241"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"es","text":"@EMA_News publicará versión final de política acceso a datos ensayos clínicos en nov-2013; entrará en vigor 1-ene-14 http://t.co/W8XNSuatG8","conversation_id":"329252660123418624","source":"Twitter Web Client","id":"329252660123418624","created_at":"2013-04-30T15:15:26.000Z","possibly_sensitive":false,"author_id":"596292370","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":117,"end":139,"url":"http://t.co/W8XNSuatG8","expanded_url":"http://bit.ly/ZTNq64","display_url":"bit.ly/ZTNq64"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"es","text":"@EMA_News publicará borrador de política sobre acceso a datos de ensayos clínicos en junio 2013 para consulta pública http://t.co/W8XNSuatG8","conversation_id":"329251621114621954","source":"Twitter Web Client","id":"329251621114621954","created_at":"2013-04-30T15:11:18.000Z","possibly_sensitive":false,"author_id":"596292370","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":118,"end":140,"url":"http://t.co/W8XNSuatG8","expanded_url":"http://bit.ly/ZTNq64","display_url":"bit.ly/ZTNq64"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"es","text":"@EMA_News está elaborando política sobre acceso a datos de ensayos clínicos, documentos de los grupos asesores en: http://t.co/W8XNSuatG8","conversation_id":"329250837002088449","source":"Twitter Web Client","id":"329250837002088449","created_at":"2013-04-30T15:08:11.000Z","possibly_sensitive":false,"author_id":"596292370","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":115,"end":137,"url":"http://t.co/W8XNSuatG8","expanded_url":"http://bit.ly/ZTNq64","display_url":"bit.ly/ZTNq64"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News publishes final advice from clinical trial advisory groups: http://t.co/U8z89fKD9a","conversation_id":"329246317706608641","source":"Twitter Web Client","id":"329246317706608641","created_at":"2013-04-30T14:50:13.000Z","possibly_sensitive":false,"author_id":"606325697","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":70,"end":92,"url":"http://t.co/U8z89fKD9a","expanded_url":"http://bit.ly/ZTNq64","display_url":"bit.ly/ZTNq64"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News recommends mkting authorisation for enzalutamide: treatmt of castration-resistant prostate cancer http://t.co/aDnLE0pIPX","conversation_id":"328896456926834688","source":"Hootsuite","id":"328896456926834688","created_at":"2013-04-29T15:40:00.000Z","possibly_sensitive":false,"author_id":"69232855","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":108,"end":130,"url":"http://t.co/aDnLE0pIPX","expanded_url":"http://ow.ly/kwVxF","display_url":"ow.ly/kwVxF"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: Two weeks left to apply for our #vacancy for #Scientist - deadline is 10 May: http://t.co/CB9BBG3V4u”@Ann_Garry","conversation_id":"328807866163146752","source":"Twitter for iPhone","id":"328818734900850689","created_at":"2013-04-29T10:31:10.000Z","possibly_sensitive":false,"author_id":"571157840","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"},{"start":113,"end":123,"username":"Ann_Garry","id":"399473636"}],"hashtags":[{"start":44,"end":52,"tag":"vacancy"},{"start":57,"end":67,"tag":"Scientist"}],"urls":[{"start":90,"end":112,"url":"http://t.co/CB9BBG3V4u","expanded_url":"http://bit.ly/10LyqVP","display_url":"bit.ly/10LyqVP"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"328807866163146752"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"es","text":"@EMA_News El CHMP en la EMA ratifica las propuestas del PRAC sobre ranelato d estroncio http://t.co/BYcJCOiqGf","conversation_id":"327742829952630784","source":"Twitter Web Client","id":"328450815264182272","created_at":"2013-04-28T10:09:11.000Z","possibly_sensitive":false,"author_id":"261573281","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":88,"end":110,"url":"http://t.co/BYcJCOiqGf","expanded_url":"http://tinyurl.com/bo9y2xw","display_url":"tinyurl.com/bo9y2xw"}],"annotations":[{"start":24,"end":26,"probability":0.8938,"type":"Organization","normalized_text":"EMA"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"327742829952630784"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"World Vet Day RT @EMA_News: We support the World Veterinary Day on 27 April, this year the theme is vaccination http://t.co/7KDv2puaQn","conversation_id":"327792403945779200","source":"Twitter for iPad","id":"327798389905444867","created_at":"2013-04-26T14:56:41.000Z","possibly_sensitive":false,"author_id":"470740219","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":17,"end":26,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":112,"end":134,"url":"http://t.co/7KDv2puaQn","expanded_url":"http://bit.ly/11pMKU9","display_url":"bit.ly/11pMKU9"}],"annotations":[{"start":0,"end":12,"probability":0.626,"type":"Other","normalized_text":"World Vet Day"},{"start":43,"end":62,"probability":0.7573,"type":"Other","normalized_text":"World Veterinary Day"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"327792403945779200"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: Meeting highlights from April #CHMP meeting have now been published: http://t.co/mEZsIeXcQN”","conversation_id":"327742015964053504","source":"Twitter for iPad","id":"327773650960908288","created_at":"2013-04-26T13:18:22.000Z","possibly_sensitive":false,"author_id":"514255564","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":42,"end":47,"tag":"CHMP"}],"urls":[{"start":81,"end":103,"url":"http://t.co/mEZsIeXcQN","expanded_url":"http://bit.ly/Y8Tjhj","display_url":"bit.ly/Y8Tjhj"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"327742015964053504"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News gives positive opinion for pan-European approval of first combined tissue-engineered medicine http://t.co/QjScZqFzHk","conversation_id":"327750548151480320","source":"Twitter for iPhone","id":"327750548151480320","created_at":"2013-04-26T11:46:34.000Z","possibly_sensitive":false,"author_id":"113148426","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":104,"end":126,"url":"http://t.co/QjScZqFzHk","expanded_url":"http://bit.ly/15VoX40","display_url":"bit.ly/15VoX40"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Great news  - we are all looking forward to reading the G#VP #guidelines!","conversation_id":"327380159386775553","source":"Twitter Web Client","id":"327483855785304065","created_at":"2013-04-25T18:06:50.000Z","possibly_sensitive":false,"author_id":"433512021","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":71,"end":82,"tag":"guidelines"}],"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"327380159386775553"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: published draft guideline on good pharmacovigilance practices - PSUR, deadline for comments is 25 June http://t.co/OItLTHG7Ux”","conversation_id":"327378632609779712","source":"Twitter for iPad","id":"327463913182609408","created_at":"2013-04-25T16:47:35.000Z","possibly_sensitive":false,"author_id":"514255564","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":115,"end":137,"url":"http://t.co/OItLTHG7Ux","expanded_url":"http://bit.ly/11Gk0qy","display_url":"bit.ly/11Gk0qy"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"327378632609779712"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: published finalised guideline on good pharmacovigilance practices - post-authorisation safety studies http://t.co/5WyJLdUw9c”","conversation_id":"327378119528955904","source":"Twitter for iPad","id":"327463822812119041","created_at":"2013-04-25T16:47:14.000Z","possibly_sensitive":false,"author_id":"514255564","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":114,"end":136,"url":"http://t.co/5WyJLdUw9c","expanded_url":"http://bit.ly/17Wojjw","display_url":"bit.ly/17Wojjw"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"327378119528955904"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: We have published initial list of medicines under additional monitoring http://t.co/UjD4xf8Trl” Black Triangle","conversation_id":"327350396001595392","source":"Twitter for iPad","id":"327462787565645826","created_at":"2013-04-25T16:43:07.000Z","possibly_sensitive":false,"author_id":"514255564","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":84,"end":106,"url":"http://t.co/UjD4xf8Trl","expanded_url":"http://bit.ly/ZK5T4L","display_url":"bit.ly/ZK5T4L"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"327350396001595392"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News listed 30 orphan drugs for additional monitoring. Learn which drugs &amp; what the new black triangle means http://t.co/XXPB8ESRxP","conversation_id":"327427151299231744","source":"Hootsuite","id":"327427151299231744","created_at":"2013-04-25T14:21:30.000Z","possibly_sensitive":false,"author_id":"26993786","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":118,"end":140,"url":"http://t.co/XXPB8ESRxP","expanded_url":"http://ow.ly/kpTJG","display_url":"ow.ly/kpTJG"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_news has published draft guideline on good pharmacovigilance practices - PSUR, deadline for comments is 25 June http://t.co/IFiiELydYO","conversation_id":"327378935836995584","source":"Twitter Web Client","id":"327378935836995584","created_at":"2013-04-25T11:09:55.000Z","possibly_sensitive":false,"author_id":"372715566","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":117,"end":139,"url":"http://t.co/IFiiELydYO","expanded_url":"http://bit.ly/11Gk0qy","display_url":"bit.ly/11Gk0qy"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News New list of medicines under additional monitoring. Encourage health profs + patients to report side effects http://t.co/CVVWZtCpTl","conversation_id":"327353455100432384","source":"Twitter for iPhone","id":"327353455100432384","created_at":"2013-04-25T09:28:40.000Z","possibly_sensitive":false,"author_id":"113148426","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":118,"end":140,"url":"http://t.co/CVVWZtCpTl","expanded_url":"http://bit.ly/ZK5T4L","display_url":"bit.ly/ZK5T4L"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"it","text":"@EMA_News pubblica una nota sui trattamenti a base di cellule staminali http://t.co/arh4g8MdAX nota originale: http://t.co/TokgorpQ0s [EN]","conversation_id":"326986676595458049","source":"TweetDeck","id":"326986676595458049","created_at":"2013-04-24T09:11:13.000Z","possibly_sensitive":false,"author_id":"441940097","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":72,"end":94,"url":"http://t.co/arh4g8MdAX","expanded_url":"http://www.agenziafarmaco.gov.it/it/content/ema-pubblica-nota-su-trattamenti-con-cellule-staminali","display_url":"agenziafarmaco.gov.it/it/content/ema…"},{"start":111,"end":133,"url":"http://t.co/TokgorpQ0s","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/04/news_detail_001769.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News publishes overview of comments received on 'Extrapolation of efficacy and safety in medicine development' http://t.co/WaNbEXK9R6","conversation_id":"326979616050917377","source":"Twitter Web Client","id":"326979616050917377","created_at":"2013-04-24T08:43:10.000Z","possibly_sensitive":false,"author_id":"1262320285","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":116,"end":138,"url":"http://t.co/WaNbEXK9R6","expanded_url":"http://bit.ly/12Hp0Oa","display_url":"bit.ly/12Hp0Oa"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Consultation documents released:\nhttp://t.co/ujkoIsc1rQ\nAnd\nhttp://t.co/xkeeYGUSxa","conversation_id":"326971330283069440","source":"Twitter Web Client","id":"326971330283069440","created_at":"2013-04-24T08:10:14.000Z","possibly_sensitive":false,"author_id":"1374194906","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":43,"end":65,"url":"http://t.co/ujkoIsc1rQ","expanded_url":"http://www.ema.europa.eu/ema/doc_index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500142008&murl=menus/document_library/document_library.jsp&mid=0b01ac058009a3dc","display_url":"ema.europa.eu/ema/doc_index.…"},{"start":70,"end":92,"url":"http://t.co/xkeeYGUSxa","expanded_url":"http://www.ema.europa.eu/ema/doc_index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500142009&murl=menus/document_library/document_library.jsp&mid=0b01ac058009a3dc","display_url":"ema.europa.eu/ema/doc_index.…"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: European Medicines Agency statement on stem cell therapy treatments http://t.co/JYNYlQyLhM”","conversation_id":"326309681138135041","source":"Twitter for iPad","id":"326325214877208578","created_at":"2013-04-22T13:22:48.000Z","possibly_sensitive":false,"author_id":"514255564","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":80,"end":102,"url":"http://t.co/JYNYlQyLhM","expanded_url":"http://bit.ly/XQT9c3","display_url":"bit.ly/XQT9c3"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"326309681138135041"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"it","text":"@EMA_News  avvia la revisione di tre #farmaci utilizzati per il trattamento dell' #ipercolesterolemia http://t.co/Dtg65bRBkB","conversation_id":"326319642232643584","source":"Twitter Web Client","id":"326319642232643584","created_at":"2013-04-22T13:00:40.000Z","possibly_sensitive":false,"author_id":"1359410448","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":37,"end":45,"tag":"farmaci"},{"start":82,"end":101,"tag":"ipercolesterolemia"}],"urls":[{"start":102,"end":124,"url":"http://t.co/Dtg65bRBkB","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2012/12/WC500136591.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"it","text":"@EMA_News aggiorna il database EudraGMP che adesso include informazioni su good distribution practices (GDP) http://t.co/gLweqKYc0M","conversation_id":"325266712100491264","source":"TweetDeck","id":"325266712100491264","created_at":"2013-04-19T15:16:41.000Z","possibly_sensitive":false,"author_id":"441940097","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":109,"end":131,"url":"http://t.co/gLweqKYc0M","expanded_url":"http://www.agenziafarmaco.gov.it/it/content/l%E2%80%99ema-aggiorna-il-database-eudragmp","display_url":"agenziafarmaco.gov.it/it/content/l%E…"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News yesterday published assessment report for #Jetrea (#ocriplasmin) for treatment of vitreomacular traction: http://t.co/OKHjWCSsan","conversation_id":"325164251696209920","source":"Twitter Web Client","id":"325164251696209920","created_at":"2013-04-19T08:29:33.000Z","possibly_sensitive":false,"author_id":"372715566","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":52,"end":59,"tag":"Jetrea"},{"start":61,"end":73,"tag":"ocriplasmin"}],"urls":[{"start":116,"end":138,"url":"http://t.co/OKHjWCSsan","expanded_url":"http://bit.ly/101GTlt","display_url":"bit.ly/101GTlt"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: Our #EudraGMP database is now #EudraGMDP - includes information on good distribution practice: http://t.co/R5x6jlJ4yN”","conversation_id":"324909174607712256","source":"Twitter for iPad","id":"324958014052388864","created_at":"2013-04-18T18:50:02.000Z","possibly_sensitive":false,"author_id":"514255564","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":16,"end":25,"tag":"EudraGMP"},{"start":42,"end":52,"tag":"EudraGMDP"}],"urls":[{"start":107,"end":129,"url":"http://t.co/R5x6jlJ4yN","expanded_url":"http://bit.ly/17rMPcb","display_url":"bit.ly/17rMPcb"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"324909174607712256"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: Our #EudraGMP database is now #EudraGMDP - includes information on good distribution practice: http://t.co/WYSklsAlQL”","conversation_id":"324909174607712256","source":"Twitter for iPhone","id":"324927381452247041","created_at":"2013-04-18T16:48:19.000Z","possibly_sensitive":false,"author_id":"339094072","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":16,"end":25,"tag":"EudraGMP"},{"start":42,"end":52,"tag":"EudraGMDP"}],"urls":[{"start":107,"end":129,"url":"http://t.co/WYSklsAlQL","expanded_url":"http://bit.ly/17rMPcb","display_url":"bit.ly/17rMPcb"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"324909174607712256"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"it","text":"@EMA_News ha pubblicato relazione pubblica di valutazione europea (EPAR) per ocriplasmina per trazione vitreomaculare http://t.co/lUanHChuoS","conversation_id":"324869562577326081","source":"TweetDeck","id":"324869562577326081","created_at":"2013-04-18T12:58:34.000Z","possibly_sensitive":false,"author_id":"441940097","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":118,"end":140,"url":"http://t.co/lUanHChuoS","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002381/human_med_001629.jsp&mid=WC0b01ac058001d124","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News publishes 2012 annual report: http://t.co/kf6NJ4czys","conversation_id":"324788131956158464","source":"Twitter Web Client","id":"324788131956158464","created_at":"2013-04-18T07:34:59.000Z","possibly_sensitive":false,"author_id":"523248351","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":40,"end":62,"url":"http://t.co/kf6NJ4czys","expanded_url":"http://bit.ly/11mv4tQ","display_url":"bit.ly/11mv4tQ"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News says it finds MAAs increasingly complex... #pharma #biotech £ http://t.co/uIQNm8AsKA","conversation_id":"324500211424714752","source":"Twitter Web Client","id":"324500211424714752","created_at":"2013-04-17T12:30:53.000Z","possibly_sensitive":false,"author_id":"249707268","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":53,"end":60,"tag":"pharma"},{"start":61,"end":69,"tag":"biotech"}],"urls":[{"start":72,"end":94,"url":"http://t.co/uIQNm8AsKA","expanded_url":"http://bit.ly/15fbp3e","display_url":"bit.ly/15fbp3e"}],"annotations":[{"start":24,"end":27,"probability":0.8597,"type":"Person","normalized_text":"MAAs"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News publishes 2012 report. Highlights: MAAs for #orphandrugs &amp; #SME applications. Focus on vaccines for #AMR  http://t.co/rbJJVCipJV","conversation_id":"324465161907884032","source":"Twitter Web Client","id":"324465161907884032","created_at":"2013-04-17T10:11:37.000Z","possibly_sensitive":false,"author_id":"1262320285","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":54,"end":66,"tag":"orphandrugs"},{"start":73,"end":77,"tag":"SME"},{"start":114,"end":118,"tag":"AMR"}],"urls":[{"start":120,"end":142,"url":"http://t.co/rbJJVCipJV","expanded_url":"http://goo.gl/3e3gq","display_url":"goo.gl/3e3gq"}],"annotations":[{"start":45,"end":48,"probability":0.7715,"type":"Person","normalized_text":"MAAs"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"it","text":"@EMA_News fornirà un parere alla Commissione Europea sull'impiego degli #antibiotici negli animali http://t.co/X3wscY6YrN","conversation_id":"324104932540162048","source":"TweetDeck","id":"324104932540162048","created_at":"2013-04-16T10:20:12.000Z","possibly_sensitive":false,"author_id":"441940097","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":72,"end":84,"tag":"antibiotici"}],"urls":[{"start":99,"end":121,"url":"http://t.co/X3wscY6YrN","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/04/news_detail_001764.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News I responded as requested - look forward to your response","conversation_id":"323754153518198785","source":"Twitter for Websites","id":"323821798225489921","created_at":"2013-04-15T15:35:07.000Z","possibly_sensitive":false,"author_id":"61387502","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"323789646054170625"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Great. Please get in touch writing to felice.drott@ages.at We are looking forward to hearing from you.","conversation_id":"321627305510309888","source":"Twitter Web Client","id":"323802795151065088","created_at":"2013-04-15T14:19:36.000Z","possibly_sensitive":false,"author_id":"223456379","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"323718025238962177"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"it","text":"@EMA_News e  #EFSA: il fenilbutazone trovato nella #carnedicavallo causa poca preoccupazione per salute consumatori http://t.co/Qny8rhRgbE","conversation_id":"323785159725948929","source":"Twitter Web Client","id":"323785159725948929","created_at":"2013-04-15T13:09:32.000Z","possibly_sensitive":false,"author_id":"84582815","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":13,"end":18,"tag":"EFSA"},{"start":51,"end":66,"tag":"carnedicavallo"}],"urls":[{"start":116,"end":138,"url":"http://t.co/Qny8rhRgbE","expanded_url":"http://bit.ly/12cjRxb","display_url":"bit.ly/12cjRxb"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"de","text":"@EMA_News und #EFSA: Phenylbutazon in #Pferdefleisch stellt geringes Risiko für die Gesundheit der Verbraucher dar. http://t.co/Qny8rhRgbE","conversation_id":"323784850798690304","source":"Twitter Web Client","id":"323784850798690304","created_at":"2013-04-15T13:08:18.000Z","possibly_sensitive":false,"author_id":"84582815","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":14,"end":19,"tag":"EFSA"},{"start":38,"end":52,"tag":"Pferdefleisch"}],"urls":[{"start":116,"end":138,"url":"http://t.co/Qny8rhRgbE","expanded_url":"http://bit.ly/12cjRxb","display_url":"bit.ly/12cjRxb"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"fr","text":"@EMA_News et #EFSA: phenylbutazone détecté dans #viandechevaline suscite faibles préoccupations pour consommateurs. http://t.co/Qny8rhRgbE","conversation_id":"323784658070425600","source":"Twitter Web Client","id":"323784658070425600","created_at":"2013-04-15T13:07:32.000Z","possibly_sensitive":false,"author_id":"84582815","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":13,"end":18,"tag":"EFSA"},{"start":48,"end":64,"tag":"viandechevaline"}],"urls":[{"start":116,"end":138,"url":"http://t.co/Qny8rhRgbE","expanded_url":"http://bit.ly/12cjRxb","display_url":"bit.ly/12cjRxb"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News @EFSA_EU  If such a 'low' concern - why still prohibited? Safe or not safe? double talk.....#foodsafety","conversation_id":"323732121011232768","source":"Twitter Web Client","id":"323772508836876290","created_at":"2013-04-15T12:19:16.000Z","possibly_sensitive":false,"author_id":"61387502","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":18,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":102,"end":113,"tag":"foodsafety"}],"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"323732121011232768"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News @EFSA_EU If such a 'low' concern - why still prohibited? Safe or not safe?  double talk.....","conversation_id":"323754153518198785","source":"Twitter Web Client","id":"323771268878979072","created_at":"2013-04-15T12:14:20.000Z","possibly_sensitive":false,"author_id":"61387502","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":18,"username":"EFSA_EU","id":"84582815"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"323754153518198785"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News and #EFSA find illegal presence of phenylbutazone detected in #horsemeat of low concern for consumers: http://t.co/Qny8rhRgbE","conversation_id":"323749791974715392","source":"Twitter Web Client","id":"323749791974715392","created_at":"2013-04-15T10:49:00.000Z","possibly_sensitive":false,"author_id":"84582815","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":14,"end":19,"tag":"EFSA"},{"start":72,"end":82,"tag":"horsemeat"}],"urls":[{"start":113,"end":135,"url":"http://t.co/Qny8rhRgbE","expanded_url":"http://bit.ly/12cjRxb","display_url":"bit.ly/12cjRxb"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":11,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: a joint report with @EFSA_EU on #phenylbutazone (#bute) in #horsemeat: low concern for consumers: http://t.co/W5wufNTIWc”","conversation_id":"323732121011232768","source":"Twitter for iPad","id":"323741385624784896","created_at":"2013-04-15T10:15:35.000Z","possibly_sensitive":false,"author_id":"514255564","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"},{"start":32,"end":40,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":44,"end":59,"tag":"phenylbutazone"},{"start":61,"end":66,"tag":"bute"},{"start":71,"end":81,"tag":"horsemeat"}],"urls":[{"start":110,"end":132,"url":"http://t.co/W5wufNTIWc","expanded_url":"http://bit.ly/10WNrUC","display_url":"bit.ly/10WNrUC"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"323732121011232768"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: On Friday we started a public consultation on the good #pharmacovigilance practices chapter on #vaccines: http://t.co/94XIxTPi28","conversation_id":"323717424581054464","source":"Twitter for iPad","id":"323741015527809024","created_at":"2013-04-15T10:14:07.000Z","possibly_sensitive":false,"author_id":"514255564","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":67,"end":85,"tag":"pharmacovigilance"},{"start":107,"end":116,"tag":"vaccines"}],"urls":[{"start":118,"end":140,"url":"http://t.co/94XIxTPi28","expanded_url":"http://bit.ly/ZlR31d","display_url":"bit.ly/ZlR31d"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"323717424581054464"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News started a public consultation on the good #pharmacovigilance practices chapter on #vaccines: http://t.co/rGHSTe6xxQ","conversation_id":"323718187852103680","source":"Twitter Web Client","id":"323718187852103680","created_at":"2013-04-15T08:43:25.000Z","possibly_sensitive":false,"author_id":"39516018","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":52,"end":70,"tag":"pharmacovigilance"},{"start":92,"end":101,"tag":"vaccines"}],"urls":[{"start":103,"end":125,"url":"http://t.co/rGHSTe6xxQ","expanded_url":"http://bit.ly/ZlR31d","display_url":"bit.ly/ZlR31d"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News  publishes module to to strengthen the conduct of #pharmacovigilance for #vaccines http://t.co/pT6MYVnu4M","conversation_id":"323712403256774656","source":"Twitter Web Client","id":"323712403256774656","created_at":"2013-04-15T08:20:25.000Z","possibly_sensitive":false,"author_id":"1262320285","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":60,"end":78,"tag":"pharmacovigilance"},{"start":83,"end":92,"tag":"vaccines"}],"urls":[{"start":93,"end":115,"url":"http://t.co/pT6MYVnu4M","expanded_url":"http://goo.gl/2NVbx","display_url":"goo.gl/2NVbx"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Will there be a report published, concerning the results of your Twitter survey? #learningbydoing","conversation_id":"321627305510309888","source":"Twitter for BlackBerry®","id":"322746461882302464","created_at":"2013-04-12T16:22:07.000Z","possibly_sensitive":false,"author_id":"223456379","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":91,"end":107,"tag":"learningbydoing"}],"urls":{},"annotations":[{"start":75,"end":81,"probability":0.5945,"type":"Product","normalized_text":"Twitter"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"321627305510309888"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News when dicelegis would be available for italy?","conversation_id":"322735118282280960","source":"Twitter for Android","id":"322735118282280960","created_at":"2013-04-12T15:37:02.000Z","possibly_sensitive":false,"author_id":"249814681","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":[{"start":48,"end":52,"probability":0.4957,"type":"Place","normalized_text":"italy"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News report shows most patients for EU clinical trials recruited outside Europe - http://t.co/XgYNmVUe3V #clinicaltrials #FP7","conversation_id":"322301023752441856","source":"TweetDeck","id":"322301023752441856","created_at":"2013-04-11T10:52:06.000Z","possibly_sensitive":false,"author_id":"47999622","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":110,"end":125,"tag":"clinicaltrials"},{"start":126,"end":130,"tag":"FP7"}],"urls":[{"start":87,"end":109,"url":"http://t.co/XgYNmVUe3V","expanded_url":"http://bit.ly/14ZOsRf","display_url":"bit.ly/14ZOsRf"}],"annotations":[{"start":78,"end":83,"probability":0.9281,"type":"Place","normalized_text":"Europe"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: We're looking to recruit a scientist to work in our Quality of Medicines Sector Apply by 10 May. details http://t.co/EoDVRv9Axz”","conversation_id":"321950928842416128","source":"Twitter for iPad","id":"322099306037387264","created_at":"2013-04-10T21:30:33.000Z","possibly_sensitive":false,"author_id":"514255564","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":117,"end":139,"url":"http://t.co/EoDVRv9Axz","expanded_url":"http://bit.ly/10LyqVP","display_url":"bit.ly/10LyqVP"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"321950928842416128"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"it","text":"@EMA_News pubblica un Rapporto sul reclutamento dei pazienti e la localizzazione geografica degli #studi #clinici http://t.co/iLMgBGHpBM","conversation_id":"321938895099027456","source":"TweetDeck","id":"321938895099027456","created_at":"2013-04-10T10:53:08.000Z","possibly_sensitive":false,"author_id":"441940097","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":98,"end":104,"tag":"studi"},{"start":105,"end":113,"tag":"clinici"}],"urls":[{"start":114,"end":136,"url":"http://t.co/iLMgBGHpBM","expanded_url":"http://www.agenziafarmaco.gov.it/it/content/l%E2%80%99ema-pubblica-un-rapporto-sul-reclutamento-dei-pazienti-e-la-localizzazione-geografica-degl","display_url":"agenziafarmaco.gov.it/it/content/l%E…"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News publishes geography of patients in trials submitted in '05-'11 MAAs. Finds 38% EU, 34% N. America, 28% ROW. http://t.co/MxuwVOBU51","conversation_id":"321924821321650176","source":"Hootsuite","id":"321924821321650176","created_at":"2013-04-10T09:57:13.000Z","possibly_sensitive":false,"author_id":"15447690","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":118,"end":140,"url":"http://t.co/MxuwVOBU51","expanded_url":"http://ow.ly/jVdtr","display_url":"ow.ly/jVdtr"}],"annotations":[{"start":100,"end":106,"probability":0.9507,"type":"Place","normalized_text":"America"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News @dianthusmed @bengoldacre @Clarejo Check this out: http://t.co/BZ8mzyUYYS #ctdata #EYC2013eo","conversation_id":"321897752504184832","source":"TweetDeck","id":"321897752504184832","created_at":"2013-04-10T08:09:39.000Z","possibly_sensitive":false,"author_id":"873777758","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":22,"username":"dianthusmed","id":"2813895984"},{"start":23,"end":35,"username":"bengoldacre","id":"6705042"},{"start":36,"end":44,"username":"Clarejo","id":"26271260"}],"hashtags":[{"start":84,"end":91,"tag":"ctdata"},{"start":92,"end":102,"tag":"EYC2013eo"}],"urls":[{"start":61,"end":83,"url":"http://t.co/BZ8mzyUYYS","expanded_url":"http://bit.ly/10Lgfzy","display_url":"bit.ly/10Lgfzy"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: Tmw publishing new #job adverts: 5 in IT and 1 in quality of medicines. Keep an eye on this Twitter feed. #recruitment”","conversation_id":"321660519696199681","source":"Twitter for iPad","id":"321720076246065152","created_at":"2013-04-09T20:23:38.000Z","possibly_sensitive":false,"author_id":"514255564","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":31,"end":35,"tag":"job"},{"start":118,"end":130,"tag":"recruitment"}],"urls":{},"annotations":[{"start":104,"end":110,"probability":0.8164,"type":"Product","normalized_text":"Twitter"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"321660519696199681"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News thanks. Your tweets are always useful and important","conversation_id":"321627305510309888","source":"Twitter for iPad","id":"321641441782796289","created_at":"2013-04-09T15:11:10.000Z","possibly_sensitive":false,"author_id":"266609916","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"321627305510309888"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News  European medicines agency glossary on regulatory terms now updated http://t.co/Gq6aIJGXP7","conversation_id":"321561036555710464","source":"Twitter Web Client","id":"321561036555710464","created_at":"2013-04-09T09:51:40.000Z","possibly_sensitive":false,"author_id":"26993786","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":78,"end":100,"url":"http://t.co/Gq6aIJGXP7","expanded_url":"http://bit.ly/14THhKw","display_url":"bit.ly/14THhKw"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":1,"like_count":4,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News revises three #guidance documents to include orphan-related information #pharma http://t.co/hqnakA78ug","conversation_id":"321286502543945728","source":"Twitter Web Client","id":"321286502543945728","created_at":"2013-04-08T15:40:46.000Z","possibly_sensitive":false,"author_id":"390850254","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":24,"end":33,"tag":"guidance"},{"start":82,"end":89,"tag":"pharma"}],"urls":[{"start":90,"end":112,"url":"http://t.co/hqnakA78ug","expanded_url":"http://regxia.com/blog/european-medicines-agency-revises-three-guidance-documents-to-include-orphan-related-information/","display_url":"regxia.com/blog/european-…"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"es","text":"@EMA_News fija los criterios que definirá qué fármacos serán considerados de alto riesgo - http://t.co/0KugDfTI2T","conversation_id":"319419325104660481","source":"Hootsuite","id":"319419325104660481","created_at":"2013-04-03T12:01:16.000Z","possibly_sensitive":false,"author_id":"153320217","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":91,"end":113,"url":"http://t.co/0KugDfTI2T","expanded_url":"http://ow.ly/jCvIJ","display_url":"ow.ly/jCvIJ"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"es","text":"@EMA_News fija los criterios que definirá qué fármacos serán considerados de alto riesgo http://t.co/ywJFzaacq5","conversation_id":"319011737150046208","source":"Hootsuite","id":"319011737150046208","created_at":"2013-04-02T09:01:39.000Z","possibly_sensitive":false,"author_id":"905430276","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":89,"end":111,"url":"http://t.co/ywJFzaacq5","expanded_url":"http://ow.ly/jCsZL","display_url":"ow.ly/jCsZL"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: assessment of safety reports on active substances in centrally and nationally authorised medicines: http://t.co/owcChVDd4I”","conversation_id":"316964370691276801","source":"Twitter for iPad","id":"317726570309644288","created_at":"2013-03-29T19:54:52.000Z","possibly_sensitive":false,"author_id":"202690721","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":112,"end":134,"url":"http://t.co/owcChVDd4I","expanded_url":"http://bit.ly/15V2Ne2","display_url":"bit.ly/15V2Ne2"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"316964370691276801"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News updated product-information templates to include #blacksymbol for medicines under additional monitoring http://t.co/AM2Ikdt7CL","conversation_id":"317048385733550081","source":"TweetDeck","id":"317048385733550081","created_at":"2013-03-27T23:00:00.000Z","possibly_sensitive":false,"author_id":"606325697","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":59,"end":71,"tag":"blacksymbol"}],"urls":[{"start":114,"end":136,"url":"http://t.co/AM2Ikdt7CL","expanded_url":"http://bit.ly/XFoqRJ","display_url":"bit.ly/XFoqRJ"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Tuesday?","conversation_id":"316838808563888130","source":"Tweetbot for iOS","id":"316918066850177024","created_at":"2013-03-27T14:22:09.000Z","possibly_sensitive":false,"author_id":"769373400","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"316838808563888130"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News updated its regulatory guidance for companies in line with new #pharmacovigilance legislation http://t.co/NGGFFsNfB1","conversation_id":"316883564467728384","source":"Twitter Web Client","id":"316883564467728384","created_at":"2013-03-27T12:05:03.000Z","possibly_sensitive":false,"author_id":"606325697","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":73,"end":91,"tag":"pharmacovigilance"}],"urls":[{"start":104,"end":126,"url":"http://t.co/NGGFFsNfB1","expanded_url":"http://bit.ly/14sHvZ0","display_url":"bit.ly/14sHvZ0"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: We've updated our guidance for pharmaceutical companies in line with the #pharmacovigilance legislation: http://t.co/niSCkvP2C7”","conversation_id":"316579188511481859","source":"Twitter for iPad","id":"316630970298150912","created_at":"2013-03-26T19:21:20.000Z","possibly_sensitive":false,"author_id":"514255564","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":85,"end":103,"tag":"pharmacovigilance"}],"urls":[{"start":117,"end":139,"url":"http://t.co/niSCkvP2C7","expanded_url":"http://bit.ly/14sHvZ0","display_url":"bit.ly/14sHvZ0"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"316579188511481859"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News  Thx 4 yr retweet!","conversation_id":"316213602409385985","source":"TweetDeck","id":"316231054182723584","created_at":"2013-03-25T16:52:13.000Z","possibly_sensitive":false,"author_id":"190227425","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"316213602409385985"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"es","text":"@EMA_News establece los criterios que determinará qué fármacos serán considerados de alto riesgo http://t.co/AdUtgJFH9b","conversation_id":"316173228798246912","source":"Hootsuite","id":"316173228798246912","created_at":"2013-03-25T13:02:26.000Z","possibly_sensitive":false,"author_id":"905430276","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":97,"end":119,"url":"http://t.co/AdUtgJFH9b","expanded_url":"http://ow.ly/jnAk4","display_url":"ow.ly/jnAk4"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"und","text":"@EMA_News","conversation_id":"316158405561688065","source":"Twitter for Android","id":"316165881476554753","created_at":"2013-03-25T12:33:14.000Z","possibly_sensitive":false,"author_id":"856967676","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"316158405561688065"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: The #CHMP recommendations are now online: http://t.co/MMfzm1jYQg”","conversation_id":"315134885364891649","source":"Twitter for iPad","id":"315201298595201024","created_at":"2013-03-22T20:40:20.000Z","possibly_sensitive":false,"author_id":"514255564","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":16,"end":21,"tag":"CHMP"}],"urls":[{"start":54,"end":76,"url":"http://t.co/MMfzm1jYQg","expanded_url":"http://bit.ly/XuKjxf","display_url":"bit.ly/XuKjxf"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"315134885364891649"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News more kittens!:) That always works.","conversation_id":"315071054940868608","source":"Twitter Web Client","id":"315071680017993728","created_at":"2013-03-22T12:05:16.000Z","possibly_sensitive":false,"author_id":"40722651","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"315071054940868608"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News   recommend restricting use of #cilostazol-containing medicines: http://t.co/2Fv2gyLp8F","conversation_id":"315050846901633025","source":"Twitter Web Client","id":"315050846901633025","created_at":"2013-03-22T10:42:29.000Z","possibly_sensitive":false,"author_id":"372715566","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":41,"end":52,"tag":"cilostazol"}],"urls":[{"start":75,"end":97,"url":"http://t.co/2Fv2gyLp8F","expanded_url":"http://bit.ly/11rcROR","display_url":"bit.ly/11rcROR"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Done","conversation_id":"314708263159611392","source":"Twitter for Android","id":"314709584679944192","created_at":"2013-03-21T12:06:26.000Z","possibly_sensitive":false,"author_id":"134450541","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"314708263159611392"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Are ATMP regs too strict? Situation not looking too good.","conversation_id":"314394141796745218","source":"Twitter Web Client","id":"314397500998041600","created_at":"2013-03-20T15:26:20.000Z","possibly_sensitive":false,"author_id":"552617924","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"314394141796745218"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: Last week we published the updated product-information templates including the #blacksymbol: http://t.co/FdVpIZvM2Z”","conversation_id":"313583567592620034","source":"Twitter for iPad","id":"313732955589713921","created_at":"2013-03-18T19:25:40.000Z","possibly_sensitive":false,"author_id":"514255564","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":91,"end":103,"tag":"blacksymbol"}],"urls":[{"start":105,"end":127,"url":"http://t.co/FdVpIZvM2Z","expanded_url":"http://bit.ly/XFoqRJ","display_url":"bit.ly/XFoqRJ"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"313583567592620034"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: We've made our submission process for applications a little simpler: http://t.co/u5fGGSwIn8”","conversation_id":"313621208849608704","source":"Twitter for iPhone","id":"313622380490653696","created_at":"2013-03-18T12:06:16.000Z","possibly_sensitive":false,"author_id":"21343575","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":81,"end":103,"url":"http://t.co/u5fGGSwIn8","expanded_url":"http://bit.ly/XO1zkL","display_url":"bit.ly/XO1zkL"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"313621208849608704"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: Our submission process for applications is now simpler: http://t.co/rgJYRaRPnR” #pharma #biotech @scripnews","conversation_id":"313583233990275073","source":"Twitter for iPad","id":"313587143001919488","created_at":"2013-03-18T09:46:15.000Z","possibly_sensitive":false,"author_id":"243228907","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":92,"end":99,"tag":"pharma"},{"start":100,"end":108,"tag":"biotech"}],"urls":[{"start":68,"end":90,"url":"http://t.co/rgJYRaRPnR","expanded_url":"http://bit.ly/XO1zkL","display_url":"bit.ly/XO1zkL"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"313583233990275073"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News renewed confidentiality agreement with @HealthCanada for further five years: http://t.co/yzzl0usiix” #pharma #biotech @scripnews","conversation_id":"313583300147027970","source":"Twitter for iPad","id":"313586999938396161","created_at":"2013-03-18T09:45:41.000Z","possibly_sensitive":false,"author_id":"243228907","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"},{"start":50,"end":63,"username":"HealthCanada","id":"928334374256472064"}],"hashtags":[{"start":112,"end":119,"tag":"pharma"},{"start":120,"end":128,"tag":"biotech"}],"urls":[{"start":88,"end":110,"url":"http://t.co/yzzl0usiix","expanded_url":"http://bit.ly/12Wa1lY","display_url":"bit.ly/12Wa1lY"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"313583300147027970"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: Last week we published updated product-information templates including #blacksymbol: http://t.co/hLYCXEkRdf” #pharma #biotech","conversation_id":"313583567592620034","source":"Twitter for iPad","id":"313586740608782336","created_at":"2013-03-18T09:44:39.000Z","possibly_sensitive":false,"author_id":"243228907","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":83,"end":95,"tag":"blacksymbol"},{"start":121,"end":128,"tag":"pharma"},{"start":129,"end":137,"tag":"biotech"}],"urls":[{"start":97,"end":119,"url":"http://t.co/hLYCXEkRdf","expanded_url":"http://bit.ly/XFoqRJ","display_url":"bit.ly/XFoqRJ"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"313583567592620034"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"und","text":"@EMA_News","conversation_id":"311883718295953408","source":"Twitter for Websites","id":"313057280876765184","created_at":"2013-03-16T22:40:46.000Z","possibly_sensitive":false,"author_id":"1038113780","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"311883718295953408"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News thanks, I did wonder if the black triangle used by the MHRA would make it :)","conversation_id":"312610428331114496","source":"Twitter for iPhone","id":"312622531305697280","created_at":"2013-03-15T17:53:14.000Z","possibly_sensitive":false,"author_id":"258074796","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"312621979746320384"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News looking forward to seeing the #blacksymbol shape","conversation_id":"312610428331114496","source":"Twitter for iPhone","id":"312616639545888768","created_at":"2013-03-15T17:29:49.000Z","possibly_sensitive":false,"author_id":"258074796","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":40,"end":52,"tag":"blacksymbol"}],"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"312610428331114496"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News updated product-information templates to include #blacksymbol for medicines under additional monitoring http://t.co/AM2Ikdt7CL","conversation_id":"312610733596737537","source":"Twitter Web Client","id":"312610733596737537","created_at":"2013-03-15T17:06:21.000Z","possibly_sensitive":false,"author_id":"606325697","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":59,"end":71,"tag":"blacksymbol"}],"urls":[{"start":114,"end":136,"url":"http://t.co/AM2Ikdt7CL","expanded_url":"http://bit.ly/XFoqRJ","display_url":"bit.ly/XFoqRJ","status":403,"unwound_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/03/news_detail_001740.jsp&mid=WC0b01ac058004d5c1"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News  Thank you so much for your retweets this week:)","conversation_id":"311884042800865281","source":"TweetDeck","id":"312593923996536832","created_at":"2013-03-15T15:59:33.000Z","possibly_sensitive":false,"author_id":"190227425","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"311884042800865281"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News releases work programme for 2013 http://t.co/Nibj5136NZ","conversation_id":"312129495828160513","source":"Twitter Web Client","id":"312129495828160513","created_at":"2013-03-14T09:14:05.000Z","possibly_sensitive":false,"author_id":"523248351","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":43,"end":65,"url":"http://t.co/Nibj5136NZ","expanded_url":"http://bit.ly/XsjaRf","display_url":"bit.ly/XsjaRf"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News For #WorldKidneyDay tomorrow, check out a free video series on making the world dialysis-free: https://t.co/PUQ2kWgbPU","conversation_id":"311946683707686912","source":"Twitter Web Client","id":"311946683707686912","created_at":"2013-03-13T21:07:39.000Z","possibly_sensitive":false,"author_id":"14759107","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":14,"end":29,"tag":"WorldKidneyDay"}],"urls":[{"start":105,"end":128,"url":"https://t.co/PUQ2kWgbPU","expanded_url":"https://hv126.infusionsoft.com/app/form/videoseries","display_url":"hv126.infusionsoft.com/app/form/video…"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News \"continue to implement the pharmacovigilance legislation, depending on resources\" -- a bit concerning!","conversation_id":"311783509633167360","source":"Twitter Web Client","id":"311784615323004930","created_at":"2013-03-13T10:23:39.000Z","possibly_sensitive":false,"author_id":"353176792","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"311783509633167360"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News New Zealand Govt Ignored US Warning on Suicide associated with Champix http://t.co/q8DDBEtUtU","conversation_id":"94059505805037568","source":"Twitter Web Client","id":"310937261510381568","created_at":"2013-03-11T02:16:34.000Z","possibly_sensitive":false,"author_id":"43524728","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":81,"end":103,"url":"http://t.co/q8DDBEtUtU","expanded_url":"http://fiddaman.blogspot.co.nz/2013/03/sometimes-new-zealand-government-get-it.html","display_url":"fiddaman.blogspot.co.nz/2013/03/someti…"}],"annotations":[{"start":10,"end":20,"probability":0.5532,"type":"Place","normalized_text":"New Zealand"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"94059505805037568"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News &amp; @EFSA_EU prepare joint statement on the risks to human health from #phenylbutazone in #horsemeat: http://t.co/sEG3zFIGAi #bute","conversation_id":"309592937036148736","source":"Twitter Web Client","id":"309592937036148736","created_at":"2013-03-07T09:14:42.000Z","possibly_sensitive":false,"author_id":"39516018","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":16,"end":24,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":83,"end":98,"tag":"phenylbutazone"},{"start":102,"end":112,"tag":"horsemeat"},{"start":137,"end":142,"tag":"bute"}],"urls":[{"start":114,"end":136,"url":"http://t.co/sEG3zFIGAi","expanded_url":"http://bit.ly/ZhSuNr","display_url":"bit.ly/ZhSuNr"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News great. Thanks so much. M.","conversation_id":"309008909677502464","source":"Twitter for Android","id":"309345554238955521","created_at":"2013-03-06T16:51:42.000Z","possibly_sensitive":false,"author_id":"266609916","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"309344865056067584"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News thanks a lot for your reaction,it was just a question to know your opinion","conversation_id":"309008909677502464","source":"Twitter for Android","id":"309344025067024384","created_at":"2013-03-06T16:45:37.000Z","possibly_sensitive":false,"author_id":"266609916","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"309232480597196800"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"und","text":"@EMA_News","conversation_id":"309008909677502464","source":"Twitter for Android","id":"309343721856585728","created_at":"2013-03-06T16:44:25.000Z","possibly_sensitive":false,"author_id":"266609916","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"309232480597196800"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Electronic cigarette, should be considered #medicaldevice? What about starting a #clinicaltrial?","conversation_id":"309008909677502464","source":"Twitter Web Client","id":"309008909677502464","created_at":"2013-03-05T18:33:59.000Z","possibly_sensitive":false,"author_id":"266609916","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":53,"end":67,"tag":"medicaldevice"},{"start":91,"end":105,"tag":"clinicaltrial"}],"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Tackling medication errors: EMA workshop calls for coordinated EU approach http://t.co/SkkiSRDrIY","conversation_id":"308618946939068416","source":"Twitter Web Client","id":"308618946939068416","created_at":"2013-03-04T16:44:25.000Z","possibly_sensitive":false,"author_id":"523248351","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":85,"end":107,"url":"http://t.co/SkkiSRDrIY","expanded_url":"http://bit.ly/YGJPW8","display_url":"bit.ly/YGJPW8"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News, @jaziehoncology, @wild_diva and @MOGA_ORG Tx for your RTs and have a great week!","conversation_id":"308256600488017920","source":"Hootsuite","id":"308256600488017920","created_at":"2013-03-03T16:44:35.000Z","possibly_sensitive":false,"author_id":"69232855","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":11,"end":26,"username":"jaziehoncology","id":"396145125"},{"start":28,"end":38,"username":"wild_diva","id":"65461631"},{"start":43,"end":52,"username":"MOGA_ORG","id":"364615723"}],"hashtags":{},"urls":{},"annotations":[{"start":53,"end":54,"probability":0.5719,"type":"Place","normalized_text":"Tx"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News I would like to work on this field. Please consider my traineeship programme application!","conversation_id":"307098183081816064","source":"Twitter Web Client","id":"307149250100330497","created_at":"2013-02-28T15:24:22.000Z","possibly_sensitive":false,"author_id":"105275296","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"307098183081816064"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Supports #RareDisease Day See what the EMA does in the rare-disease area: http://t.co/IesLjNTeSP","conversation_id":"307064921462566912","source":"Twitter Web Client","id":"307064921462566912","created_at":"2013-02-28T09:49:16.000Z","possibly_sensitive":false,"author_id":"523248351","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":19,"end":31,"tag":"RareDisease"}],"urls":[{"start":84,"end":106,"url":"http://t.co/IesLjNTeSP","expanded_url":"http://bit.ly/13kxyMK","display_url":"bit.ly/13kxyMK"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News updated guidance for #pharmaceutical firms to include information on #orphan medicines: http://t.co/ZTTUWcoWQZ” #biotech #pharma","conversation_id":"306694650406780928","source":"Twitter for iPad","id":"306696247408996352","created_at":"2013-02-27T09:24:18.000Z","possibly_sensitive":false,"author_id":"243228907","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":32,"end":47,"tag":"pharmaceutical"},{"start":80,"end":87,"tag":"orphan"},{"start":123,"end":131,"tag":"biotech"},{"start":132,"end":139,"tag":"pharma"}],"urls":[{"start":99,"end":121,"url":"http://t.co/ZTTUWcoWQZ","expanded_url":"http://bit.ly/13ePqZu","display_url":"bit.ly/13ePqZu"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"306694650406780928"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: We've updated our guidance for pharmaceutical companies to include information on #orphan medicines: http://t.co/AAFqpQcnh1”","conversation_id":"306415672701890560","source":"Twitter for iPad","id":"306503395013967874","created_at":"2013-02-26T20:37:58.000Z","possibly_sensitive":false,"author_id":"514255564","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":94,"end":101,"tag":"orphan"}],"urls":[{"start":113,"end":135,"url":"http://t.co/AAFqpQcnh1","expanded_url":"http://bit.ly/13ePqZu","display_url":"bit.ly/13ePqZu"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"306415672701890560"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News - what is the view of EMA on the off-label use of Cytotec - #ANSM #France  | @scoopit http://t.co/CWg0UH52g3","conversation_id":"306369611337695232","source":"Scoop.it","id":"306369611337695232","created_at":"2013-02-26T11:46:22.000Z","possibly_sensitive":false,"author_id":"368277484","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":87,"end":95,"username":"scoopit","id":"209484168"}],"hashtags":[{"start":70,"end":75,"tag":"ANSM"},{"start":76,"end":83,"tag":"France"}],"urls":[{"start":96,"end":118,"url":"http://t.co/CWg0UH52g3","expanded_url":"http://sco.lt/7CHGSn","display_url":"sco.lt/7CHGSn"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: List of #CHMP recommendations from February meeting: http://t.co/p2zF7ZJQ0D”","conversation_id":"306079626982203394","source":"Twitter for iPad","id":"306165089705271296","created_at":"2013-02-25T22:13:40.000Z","possibly_sensitive":false,"author_id":"514255564","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":20,"end":25,"tag":"CHMP"}],"urls":[{"start":65,"end":87,"url":"http://t.co/p2zF7ZJQ0D","expanded_url":"http://bit.ly/XQbxNZ","display_url":"bit.ly/XQbxNZ"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"306079626982203394"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: We're expecting our #fees for applications to be going up by about 2.6% on 1 April 2013: http://t.co/rcd9ALju1W”","conversation_id":"306032477779144705","source":"Twitter for iPad","id":"306164621776130051","created_at":"2013-02-25T22:11:48.000Z","possibly_sensitive":false,"author_id":"514255564","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":32,"end":37,"tag":"fees"}],"urls":[{"start":101,"end":123,"url":"http://t.co/rcd9ALju1W","expanded_url":"http://bit.ly/ZDygDC","display_url":"bit.ly/ZDygDC"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"306032477779144705"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News ok thanks for information !","conversation_id":"305978870065139712","source":"Twitter for iPhone","id":"306067898701578240","created_at":"2013-02-25T15:47:28.000Z","possibly_sensitive":false,"author_id":"556679074","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"305979166459850752"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News expects its drug application fees to increase by around 2.6% from 1 April","conversation_id":"305989257045094400","source":"Twitter Web Client","id":"305989257045094400","created_at":"2013-02-25T10:34:58.000Z","possibly_sensitive":false,"author_id":"459335626","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: Meeting highlights from the February 2013 #CHMP: http://t.co/p2zF7ZJQ0D”","conversation_id":"304926862893789184","source":"Twitter for iPad","id":"305043590986469376","created_at":"2013-02-22T19:57:14.000Z","possibly_sensitive":false,"author_id":"514255564","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":54,"end":59,"tag":"CHMP"}],"urls":[{"start":61,"end":83,"url":"http://t.co/p2zF7ZJQ0D","expanded_url":"http://bit.ly/XQbxNZ","display_url":"bit.ly/XQbxNZ"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"304926862893789184"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@ema_news #CHMP recommends #EU approval of @sanofi 6-in-1 pediatric #vaccine vs #diphtheria, tetanus, #pertusis, #hepatitis B, #polio &amp; #Hib","conversation_id":"304955126555234304","source":"Hootsuite","id":"304955126555234304","created_at":"2013-02-22T14:05:42.000Z","possibly_sensitive":false,"author_id":"243228907","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":43,"end":50,"username":"sanofi","id":"35846368"}],"hashtags":[{"start":10,"end":15,"tag":"CHMP"},{"start":27,"end":30,"tag":"EU"},{"start":68,"end":76,"tag":"vaccine"},{"start":80,"end":91,"tag":"diphtheria"},{"start":102,"end":111,"tag":"pertusis"},{"start":113,"end":123,"tag":"hepatitis"},{"start":127,"end":133,"tag":"polio"},{"start":140,"end":144,"tag":"Hib"}],"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"und","text":"@EMA_News http://t.co/SFfv9NUh9V","conversation_id":"304935458977234946","source":"Twitter Web Client","id":"304935458977234946","created_at":"2013-02-22T12:47:33.000Z","possibly_sensitive":false,"author_id":"1182633590","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":10,"end":32,"url":"http://t.co/SFfv9NUh9V","expanded_url":"http://xcturkey.info/sFCrIS","display_url":"xcturkey.info/sFCrIS"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: Meeting highlights from the February 2013 #CHMP: http://t.co/EHL9TbPKVz”","conversation_id":"304926862893789184","source":"Twitter for iPhone","id":"304930629693341696","created_at":"2013-02-22T12:28:22.000Z","possibly_sensitive":false,"author_id":"339094072","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":54,"end":59,"tag":"CHMP"}],"urls":[{"start":61,"end":83,"url":"http://t.co/EHL9TbPKVz","expanded_url":"http://bit.ly/XQbxNZ","display_url":"bit.ly/XQbxNZ"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"304926862893789184"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News CHMP confirms refusal to recommend marketing authorisation for #Qsiva (phentermine /topiramate) for obesity #pharma #biotech...","conversation_id":"304930401963626496","source":"Hootsuite","id":"304930401963626496","created_at":"2013-02-22T12:27:27.000Z","possibly_sensitive":false,"author_id":"243228907","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":73,"end":79,"tag":"Qsiva"},{"start":118,"end":125,"tag":"pharma"},{"start":126,"end":134,"tag":"biotech"}],"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@ema_news #CHMP recommends approval of #memantine hydrochloride generics from #Actavis &amp; #Generics UK to treat #Alzheimer's disease #pharma","conversation_id":"304930176872116224","source":"Hootsuite","id":"304930176872116224","created_at":"2013-02-22T12:26:34.000Z","possibly_sensitive":false,"author_id":"243228907","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":15,"tag":"CHMP"},{"start":39,"end":49,"tag":"memantine"},{"start":78,"end":86,"tag":"Actavis"},{"start":93,"end":102,"tag":"Generics"},{"start":115,"end":125,"tag":"Alzheimer"},{"start":136,"end":143,"tag":"pharma"}],"urls":{},"annotations":[{"start":99,"end":100,"probability":0.9326,"type":"Place","normalized_text":"UK"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@ema_news CHMP confirms refusal to reommend marketing authorisation for #Qsiva (phentermine /topiramate) for obesity #pharma #biotech #Vivus","conversation_id":"304929450024394754","source":"Hootsuite","id":"304929450024394754","created_at":"2013-02-22T12:23:40.000Z","possibly_sensitive":false,"author_id":"243228907","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":72,"end":78,"tag":"Qsiva"},{"start":117,"end":124,"tag":"pharma"},{"start":125,"end":133,"tag":"biotech"},{"start":134,"end":140,"tag":"Vivus"}],"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News @CariinaL Have a look! #PIPs","conversation_id":"304926158359785472","source":"Twitter Web Client","id":"304929369376292864","created_at":"2013-02-22T12:23:21.000Z","possibly_sensitive":false,"author_id":"120927719","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":19,"username":"CariinaL","id":"70110648"}],"hashtags":[{"start":33,"end":38,"tag":"PIPs"}],"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"304926158359785472"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@ema_news confirms Novartis Europharm is withdrawing its MAA for Ruvise imatinib to treat pulmonary arterial hypertension #pharma","conversation_id":"304928649344331776","source":"Hootsuite","id":"304928649344331776","created_at":"2013-02-22T12:20:29.000Z","possibly_sensitive":false,"author_id":"243228907","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":122,"end":129,"tag":"pharma"}],"urls":{},"annotations":[{"start":19,"end":36,"probability":0.255,"type":"Person","normalized_text":"Novartis Europharm"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"ro","text":"@ema_news opens public consultation on PIPs for 2 specific unmet pediatric #cancer types acute myeloid leukaemia &amp; rhabdomyosarcoma #pharma","conversation_id":"304919472010035200","source":"Hootsuite","id":"304919472010035200","created_at":"2013-02-22T11:44:01.000Z","possibly_sensitive":false,"author_id":"243228907","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":75,"end":82,"tag":"cancer"},{"start":136,"end":143,"tag":"pharma"}],"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Thank you EMA for your attention in pediatrics. I hope that you will also have future plans for pediatric drugs development","conversation_id":"304587198227943426","source":"Twitter Web Client","id":"304600854965665792","created_at":"2013-02-21T14:37:57.000Z","possibly_sensitive":false,"author_id":"1050145740","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"304587198227943426"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: #PROTECT has launched two new databases #pharmacovigilance activities #pharmacoepidemiological studies http://t.co/3hqLPMiD","conversation_id":"303849645493342210","source":"Twitter for iPad","id":"303932836661051392","created_at":"2013-02-19T18:23:29.000Z","possibly_sensitive":false,"author_id":"514255564","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":12,"end":20,"tag":"PROTECT"},{"start":52,"end":70,"tag":"pharmacovigilance"},{"start":82,"end":106,"tag":"pharmacoepidemiological"}],"urls":[{"start":115,"end":135,"url":"http://t.co/3hqLPMiD","expanded_url":"http://bit.ly/XqXrVR","display_url":"bit.ly/XqXrVR"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"303849645493342210"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"et","text":"@EMA_News @HAS_sante EMA- Pharmacovigilance Risk Assessment Committee (PRAC) invites sta... | @scoopit http://t.co/rNfWjEGY","conversation_id":"303802809986453504","source":"Scoop.it","id":"303802809986453504","created_at":"2013-02-19T09:46:48.000Z","possibly_sensitive":false,"author_id":"368277484","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":20,"username":"HAS_sante","id":"395293321"},{"start":94,"end":102,"username":"scoopit","id":"209484168"}],"hashtags":{},"urls":[{"start":103,"end":123,"url":"http://t.co/rNfWjEGY","expanded_url":"http://sco.lt/7F1J57","display_url":"sco.lt/7F1J57"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"it","text":"@EMA_News #salute Sostegno AIFA all’EMA attaccata perché troppo trasparente\nhttp://t.co/jmApsJXj","conversation_id":"303537660486635521","source":"Twitter Web Client","id":"303537660486635521","created_at":"2013-02-18T16:13:12.000Z","possibly_sensitive":false,"author_id":"266609916","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":17,"tag":"salute"}],"urls":[{"start":76,"end":96,"url":"http://t.co/jmApsJXj","expanded_url":"http://www.agenziafarmaco.gov.it/it/content/sostegno-aifa-all%E2%80%99ema-attaccata-perch%C3%A9-troppo-trasparente-0","display_url":"agenziafarmaco.gov.it/it/content/sos…"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News, @AB_CancerCPGs, @MaverickNY, @BreastOncology, @PhysRelations, @Krasnozhon, @Grifondoro67, @infolibri thank you for yr RTs/MTs","conversation_id":"303188035158286338","source":"Hootsuite","id":"303188035158286338","created_at":"2013-02-17T17:03:55.000Z","possibly_sensitive":false,"author_id":"69232855","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":11,"end":25,"username":"AB_CancerCPGs","id":"217172598"},{"start":27,"end":38,"username":"MaverickNY","id":"13649002"},{"start":40,"end":55,"username":"BreastOncology","id":"719804523208974336"},{"start":73,"end":84,"username":"Krasnozhon","id":"104254896"},{"start":86,"end":99,"username":"Grifondoro67","id":"360918486"},{"start":101,"end":111,"username":"infolibri","id":"395136825"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: This year our #veterinary committee is focusing on #antimicrobial #resistance and quality assurance: http://t.co/nvIJAegN”","conversation_id":"302454312460754944","source":"Twitter for iPad","id":"302501396488519681","created_at":"2013-02-15T19:35:27.000Z","possibly_sensitive":false,"author_id":"514255564","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":26,"end":37,"tag":"veterinary"},{"start":63,"end":77,"tag":"antimicrobial"},{"start":78,"end":89,"tag":"resistance"}],"urls":[{"start":113,"end":133,"url":"http://t.co/nvIJAegN","expanded_url":"http://bit.ly/ZfyiS5","display_url":"bit.ly/ZfyiS5"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"302454312460754944"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"“@EMA_News: We published the highlights from our most recent #pharmavcovigilance committee (#PRAC) meeting last week: http://t.co/fGeCB1Jj","conversation_id":"302396853138362370","source":"Twitter for iPad","id":"302500158908817408","created_at":"2013-02-15T19:30:32.000Z","possibly_sensitive":false,"author_id":"514255564","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":61,"end":80,"tag":"pharmavcovigilance"},{"start":92,"end":97,"tag":"PRAC"}],"urls":[{"start":118,"end":138,"url":"http://t.co/fGeCB1Jj","expanded_url":"http://bit.ly/WyAhy0","display_url":"bit.ly/WyAhy0"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"302396853138362370"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News adopts ICH Q11 guidance on manufacturing drug substances: http://t.co/pOZkFfUB","conversation_id":"302475781009981440","source":"Twitter Web Client","id":"302475781009981440","created_at":"2013-02-15T17:53:40.000Z","possibly_sensitive":false,"author_id":"605657704","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":68,"end":88,"url":"http://t.co/pOZkFfUB","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/05/WC500127803.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News @Leem Novo to sell Tresiba in Europe at 60-70 percent premium over Lantus | @scoopit http://t.co/8B7RoBtT","conversation_id":"302425874760863745","source":"Scoop.it","id":"302425874760863745","created_at":"2013-02-15T14:35:22.000Z","possibly_sensitive":false,"author_id":"368277484","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":15,"username":"leem","id":"821214"},{"start":86,"end":94,"username":"scoopit","id":"209484168"}],"hashtags":{},"urls":[{"start":95,"end":115,"url":"http://t.co/8B7RoBtT","expanded_url":"http://sco.lt/7ChEWH","display_url":"sco.lt/7ChEWH"}],"annotations":[{"start":40,"end":45,"probability":0.9635,"type":"Place","normalized_text":"Europe"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News reaction from the HAS http://t.co/JWGaJZVN","conversation_id":"302084728733962240","source":"Twitter Web Client","id":"302084728733962240","created_at":"2013-02-14T15:59:46.000Z","possibly_sensitive":false,"author_id":"368277484","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":32,"end":52,"url":"http://t.co/JWGaJZVN","expanded_url":"http://sco.lt/79j2sj","display_url":"sco.lt/79j2sj"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News eSub Gateway release II and eSub web client now live for all applications for human medicines #EMA #eCTD http://t.co/uiDkNTsc","conversation_id":"301696990482411523","source":"Twitter Web Client","id":"301696990482411523","created_at":"2013-02-13T14:19:02.000Z","possibly_sensitive":false,"author_id":"390850254","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":104,"end":108,"tag":"EMA"},{"start":109,"end":114,"tag":"eCTD"}],"urls":[{"start":115,"end":135,"url":"http://t.co/uiDkNTsc","expanded_url":"http://regxia.com/blog","display_url":"regxia.com/blog"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News What is the EMA view on statins? France is preparing for a new battle on that topic!","conversation_id":"301641394571841537","source":"Twitter Web Client","id":"301641394571841537","created_at":"2013-02-13T10:38:07.000Z","possibly_sensitive":false,"author_id":"368277484","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":[{"start":43,"end":48,"probability":0.8301,"type":"Place","normalized_text":"France"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"es","text":"@EMA_News comienza revisión de #Diane35  http://t.co/CYqKCiqm en #Colombia altas ventas http://t.co/hxNa9DgH @invimacolombia @minsaludcol","conversation_id":"299896365125873665","source":"Hootsuite","id":"299896365125873665","created_at":"2013-02-08T15:03:59.000Z","possibly_sensitive":false,"author_id":"239671836","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":109,"end":124,"username":"invimacolombia","id":"374557401"},{"start":125,"end":137,"username":"MinSaludCol","id":"371797057"}],"hashtags":[{"start":31,"end":39,"tag":"Diane35"},{"start":65,"end":74,"tag":"Colombia"}],"urls":[{"start":41,"end":61,"url":"http://t.co/CYqKCiqm","expanded_url":"http://ow.ly/hxIhq","display_url":"ow.ly/hxIhq"},{"start":88,"end":108,"url":"http://t.co/hxNa9DgH","expanded_url":"http://ow.ly/hjvOj","display_url":"ow.ly/hjvOj"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News, @BrandcastHealth, @wild_diva, @AB_CancerCPGs, @BreastOncology, @evepie, @EPAAC_JA, @epgonline, @EvePierron Tx for yr RTs/MTs!","conversation_id":"298089068280049665","source":"Hootsuite","id":"298089068280049665","created_at":"2013-02-03T15:22:26.000Z","possibly_sensitive":false,"author_id":"69232855","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":11,"end":27,"username":"BrandcastHealth","id":"2306341848"},{"start":29,"end":39,"username":"wild_diva","id":"65461631"},{"start":41,"end":55,"username":"AB_CancerCPGs","id":"217172598"},{"start":57,"end":72,"username":"BreastOncology","id":"719804523208974336"},{"start":74,"end":81,"username":"EVEPIE","id":"134450541"},{"start":83,"end":92,"username":"EPAAC_JA","id":"266490349"},{"start":94,"end":104,"username":"epgonline","id":"1272180037689716736"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News what about the legal aspects regarding #biosimilars ? Will that not be a problem in the EU/EEA?","conversation_id":"297034154741227520","source":"Twitter Web Client","id":"297035431546089472","created_at":"2013-01-31T17:35:40.000Z","possibly_sensitive":false,"author_id":"40722651","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":49,"end":61,"tag":"biosimilars"}],"urls":{},"annotations":[{"start":98,"end":99,"probability":0.5669,"type":"Organization","normalized_text":"EU"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"297034154741227520"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News First meeting of the Modelling and Simulation Working Group","conversation_id":"297032871284187136","source":"Twitter Web Client","id":"297032871284187136","created_at":"2013-01-31T17:25:29.000Z","possibly_sensitive":false,"author_id":"523248351","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"pt","text":"@EMA_News\nSuspensão da AIM em França dos medicamentos que contêm acetato de ciproterona 2 mg + etinilestradiol 35 µg.\nhttp://t.co/Mcud9qBM","conversation_id":"297012849803423745","source":"Twitter Web Client","id":"297012849803423745","created_at":"2013-01-31T16:05:56.000Z","possibly_sensitive":false,"author_id":"120927719","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":118,"end":138,"url":"http://t.co/Mcud9qBM","expanded_url":"http://www.infarmed.pt/portal/page/portal/INFARMED/MAIS_ALERTAS/DETALHE_ALERTA?itemid=6715760","display_url":"infarmed.pt/portal/page/po…"}],"annotations":[{"start":30,"end":35,"probability":0.9797,"type":"Place","normalized_text":"França"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":".@EMA_News Let us know when you're looking for volunteers to test your information published as #LinkedData http://t.co/LJt7E2ga","conversation_id":"296544056316661760","source":"Twitter for iPhone","id":"296647875608313857","created_at":"2013-01-30T15:55:39.000Z","possibly_sensitive":false,"author_id":"144624330","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":96,"end":107,"tag":"LinkedData"}],"urls":[{"start":108,"end":128,"url":"http://t.co/LJt7E2ga","expanded_url":"http://5stardata.info/","display_url":"5stardata.info"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"296544056316661760"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Registration now open for EMA/IFAH-Europe Infoday, London, 7-8 March 2013: http://t.co/Ool6x3TC","conversation_id":"296567380639899648","source":"Twitter Web Client","id":"296567380639899648","created_at":"2013-01-30T10:35:48.000Z","possibly_sensitive":false,"author_id":"1017044760","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":85,"end":105,"url":"http://t.co/Ool6x3TC","expanded_url":"http://www.ifaheurope.org/EventDetails.aspx?ID=166&SubMenuId=26&MenuId=4","display_url":"ifaheurope.org/EventDetails.a…"}],"annotations":[{"start":45,"end":58,"probability":0.653,"type":"Place","normalized_text":"Europe Infoday"},{"start":61,"end":66,"probability":0.8593,"type":"Place","normalized_text":"London"}],"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"Safety of contraceptive pill (3rd+4th generation) called into question. EU Medicines Agency investigates. \n@EMA_News http://t.co/ik9wZDSH","conversation_id":"296562521039593472","source":"Twitter Web Client","id":"296562521039593472","created_at":"2013-01-30T10:16:29.000Z","possibly_sensitive":false,"author_id":"237222584","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":107,"end":116,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":117,"end":137,"url":"http://t.co/ik9wZDSH","expanded_url":"http://bit.ly/T9jMrF","display_url":"bit.ly/T9jMrF"}],"annotations":[{"start":72,"end":90,"probability":0.6777,"type":"Organization","normalized_text":"EU Medicines Agency"}],"cashtags":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News : Thank you for Retweeting!","conversation_id":"296161709910020096","source":"Twitter Web Client","id":"296161709910020096","created_at":"2013-01-29T07:43:48.000Z","possibly_sensitive":false,"author_id":"487344065","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News to review 3rd- and 4th-generation combined oral  contraceptives after death cases in France: http://t.co/Fymbajmd @mutualite_fr","conversation_id":"295946739976921088","source":"Twitter Web Client","id":"295946739976921088","created_at":"2013-01-28T17:29:35.000Z","possibly_sensitive":false,"author_id":"784869524","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":124,"end":137,"username":"mutualite_fr","id":"255999421"}],"hashtags":{},"urls":[{"start":103,"end":123,"url":"http://t.co/Fymbajmd","expanded_url":"http://bit.ly/VrWcIJ","display_url":"bit.ly/VrWcIJ"}],"annotations":[{"start":95,"end":100,"probability":0.9943,"type":"Place","normalized_text":"France"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News, @lucidaMC, @aftimosp, @brandcasthealth, @mlazqui, @jaziehoncology, @BreastOncology, @uroweb thank U for yr kind RTs/MTs","conversation_id":"295521012932558848","source":"Hootsuite","id":"295521012932558848","created_at":"2013-01-27T13:17:54.000Z","possibly_sensitive":false,"author_id":"69232855","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":11,"end":20,"username":"lucidaMC","id":"239863785"},{"start":22,"end":31,"username":"aftimosp","id":"177176270"},{"start":33,"end":49,"username":"BrandcastHealth","id":"2306341848"},{"start":51,"end":59,"username":"mlazqui","id":"196132848"},{"start":61,"end":76,"username":"jaziehoncology","id":"396145125"},{"start":78,"end":93,"username":"BreastOncology","id":"719804523208974336"},{"start":95,"end":102,"username":"Uroweb","id":"114455333"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News publishes guidance on preparing &amp; reviewing summaries of product characteristics http://t.co/cTcPaAJ1 #EMA","conversation_id":"294814690788384771","source":"bitly bitlink","id":"294814690788384771","created_at":"2013-01-25T14:31:14.000Z","possibly_sensitive":false,"author_id":"184778250","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":116,"end":120,"tag":"EMA"}],"urls":[{"start":95,"end":115,"url":"http://t.co/cTcPaAJ1","expanded_url":"http://bit.ly/W6XV3K","display_url":"bit.ly/W6XV3K"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News updated the table template for companies submitting dossiers on #medicines http://t.co/HVUdFMfO  #pharmacovigilance","conversation_id":"294803735518007297","source":"Twitter Web Client","id":"294803735518007297","created_at":"2013-01-25T13:47:42.000Z","possibly_sensitive":false,"author_id":"606325697","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":74,"end":84,"tag":"medicines"},{"start":107,"end":125,"tag":"pharmacovigilance"}],"urls":[{"start":85,"end":105,"url":"http://t.co/HVUdFMfO","expanded_url":"http://bit.ly/VlxSrR","display_url":"bit.ly/VlxSrR"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News thanks for your quick RT!","conversation_id":"294752367256166400","source":"Twitter Web Client","id":"294752367256166400","created_at":"2013-01-25T10:23:35.000Z","possibly_sensitive":false,"author_id":"114455333","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News  puts out guidance on preparing and reviewing SmPCs http://t.co/NNanEo7T","conversation_id":"293640996015710209","source":"Twitter Web Client","id":"293640996015710209","created_at":"2013-01-22T08:47:23.000Z","possibly_sensitive":false,"author_id":"605657704","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":62,"end":82,"url":"http://t.co/NNanEo7T","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/01/news_detail_001691.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News thanks for that information, but that doesn't answer lorcaserin","conversation_id":"292219288763387904","source":"Twitter Web Client","id":"292307817480732672","created_at":"2013-01-18T16:29:49.000Z","possibly_sensitive":false,"author_id":"85798840","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"292219288763387904"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News is there an expected date?","conversation_id":"292219288763387904","source":"Twitter Web Client","id":"292306888912150528","created_at":"2013-01-18T16:26:07.000Z","possibly_sensitive":false,"author_id":"85798840","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"292305360100933632"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News what is the status of lorcaserin","conversation_id":"292219288763387904","source":"Twitter Web Client","id":"292304798869491712","created_at":"2013-01-18T16:17:49.000Z","possibly_sensitive":false,"author_id":"85798840","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"292219288763387904"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News When will we see a positive recommendation for Belviq by Arena Pharm.","conversation_id":"292247618648686592","source":"Twitter Web Client","id":"292251315793457152","created_at":"2013-01-18T12:45:18.000Z","possibly_sensitive":false,"author_id":"140040713","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":[{"start":57,"end":62,"probability":0.3876,"type":"Person","normalized_text":"Belviq"},{"start":67,"end":77,"probability":0.9015,"type":"Organization","normalized_text":"Arena Pharm"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"292247618648686592"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News  Is Belviq by Arena Pharm. on the agenda for today?","conversation_id":"292244377999388672","source":"Twitter Web Client","id":"292245752372133891","created_at":"2013-01-18T12:23:11.000Z","possibly_sensitive":false,"author_id":"140040713","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":[{"start":24,"end":34,"probability":0.8224,"type":"Organization","normalized_text":"Arena Pharm"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"292244377999388672"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@ema_news Any info regarding Arena Pharmaceuticals coming soon?","conversation_id":"292244621730385921","source":"Twitter for iPhone","id":"292244621730385921","created_at":"2013-01-18T12:18:42.000Z","possibly_sensitive":false,"author_id":"906195691","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":[{"start":29,"end":49,"probability":0.6578,"type":"Organization","normalized_text":"Arena Pharmaceuticals"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"place_id":"17998f6e86018300","coordinates":{"type":"Point","coordinates":[-75.4267,40.0736]}}},{"lang":"en","text":"@EMA_News Committee confirms recommendation to suspend #Tredaptive,#Pelzont and #Trevaclyn: http://t.co/TXCU22fi","conversation_id":"292236987656720385","source":"Twitter Web Client","id":"292236987656720385","created_at":"2013-01-18T11:48:22.000Z","possibly_sensitive":false,"author_id":"606325697","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":55,"end":66,"tag":"Tredaptive"},{"start":67,"end":75,"tag":"Pelzont"},{"start":80,"end":90,"tag":"Trevaclyn"}],"urls":[{"start":92,"end":112,"url":"http://t.co/TXCU22fi","expanded_url":"http://bit.ly/UULYeg","display_url":"bit.ly/UULYeg"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"RT @epha_eu: European Medicines Agency updates guideline on evaluation of  #anticancer medicines: http://t.co/wntwczJ2 \n@EMA_News #cancer","conversation_id":"291560405602541569","source":"Hootsuite","id":"291560405602541569","created_at":"2013-01-16T14:59:52.000Z","possibly_sensitive":false,"author_id":"85289564","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":3,"end":11,"username":"EPHA_EU","id":"184756856"},{"start":120,"end":129,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":75,"end":86,"tag":"anticancer"},{"start":130,"end":137,"tag":"cancer"}],"urls":[{"start":98,"end":118,"url":"http://t.co/wntwczJ2","expanded_url":"http://bit.ly/Y9nqoe","display_url":"bit.ly/Y9nqoe"}],"annotations":[{"start":13,"end":37,"probability":0.5442,"type":"Organization","normalized_text":"European Medicines Agency"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"European Medicines Agency updates guideline on evaluation of  #anticancer medicines: http://t.co/agZaB5ev \n@EMA_News #cancer","conversation_id":"291558786135642112","source":"Twitter Web Client","id":"291558786135642112","created_at":"2013-01-16T14:53:26.000Z","possibly_sensitive":false,"author_id":"184756856","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":107,"end":116,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":62,"end":73,"tag":"anticancer"},{"start":117,"end":124,"tag":"cancer"}],"urls":[{"start":85,"end":105,"url":"http://t.co/agZaB5ev","expanded_url":"http://bit.ly/Y9nqoe","display_url":"bit.ly/Y9nqoe"}],"annotations":[{"start":0,"end":24,"probability":0.5564,"type":"Organization","normalized_text":"European Medicines Agency"}],"cashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@ema_news You are welcome. I also like to be informed if that happened in our website. It can happen, we are human :)","conversation_id":"291215856317378561","source":"Hootsuite","id":"291219228814618624","created_at":"2013-01-15T16:24:09.000Z","possibly_sensitive":false,"author_id":"66679860","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"291216239345410048"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News On your website there is a mistake here http://t.co/njjC4b0B wrong date 15/01/2014, should be 2013 :) Have a nice evening","conversation_id":"291215856317378561","source":"Hootsuite","id":"291215856317378561","created_at":"2013-01-15T16:10:45.000Z","possibly_sensitive":false,"author_id":"66679860","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":50,"end":70,"url":"http://t.co/njjC4b0B","expanded_url":"http://ow.ly/gPAH9","display_url":"ow.ly/gPAH9"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Thank you for the retweet!","conversation_id":"291209599753797635","source":"Twitter Web Client","id":"291209599753797635","created_at":"2013-01-15T15:45:53.000Z","possibly_sensitive":false,"author_id":"198970635","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News  FDA 2013 tentative calendar - Let's see what we have in store on this side of the pond to match that....\nhttp://t.co/OpI4Osz2","conversation_id":"288332079643643904","source":"Twitter Web Client","id":"288332079643643904","created_at":"2013-01-07T17:11:39.000Z","possibly_sensitive":false,"author_id":"201654484","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":116,"end":136,"url":"http://t.co/OpI4Osz2","expanded_url":"http://www.fda.gov/AdvisoryCommittees/Calendar/ucm153468.htm","display_url":"fda.gov/AdvisoryCommit…"}],"annotations":[{"start":11,"end":13,"probability":0.5361,"type":"Organization","normalized_text":"FDA"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"RT @EMA_News We recommended the approval of Lundbeck's #Selincro, a medicine for reduction of alcohol consumption: http://t.co/rLZYLp5E","conversation_id":"280644430581624834","source":"Twitter Web Client","id":"280645871832539136","created_at":"2012-12-17T12:09:24.000Z","possibly_sensitive":false,"author_id":"249707268","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":55,"end":64,"tag":"Selincro"}],"urls":[{"start":115,"end":135,"url":"http://t.co/rLZYLp5E","expanded_url":"http://bit.ly/SocbpA","display_url":"bit.ly/SocbpA"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"280644430581624834"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News How do you keep up with trends and news in #Healthcare?","conversation_id":"280329106732744706","source":"SipSocial App","id":"280329106732744706","created_at":"2012-12-16T15:10:41.000Z","possibly_sensitive":false,"author_id":"312029599","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":53,"end":64,"tag":"Healthcare"}],"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Thanks for the retweet! Much appreciated.","conversation_id":"278814278671294464","source":"Twitter Web Client","id":"278814278671294464","created_at":"2012-12-12T10:51:18.000Z","possibly_sensitive":false,"author_id":"203357203","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Report from #CTdata workshop http://t.co/xDUISarV Sadly missing my suggestion to lock participants in room for 48hrs to sort out","conversation_id":"276832425894637568","source":"Twitter for iPhone","id":"276832425894637568","created_at":"2012-12-06T23:36:08.000Z","possibly_sensitive":false,"author_id":"22394209","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":22,"end":29,"tag":"CTdata"}],"urls":[{"start":39,"end":59,"url":"http://t.co/xDUISarV","expanded_url":"http://bit.ly/VwuSbA","display_url":"bit.ly/VwuSbA"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News, @AB_CancerCPGs, @carisa_za, @jaziehoncology, @mlazqui, @Annals_Oncology, @EORTC, @BKKommunikation tx for yr RTs!","conversation_id":"276438072059633664","source":"Hootsuite","id":"276438072059633664","created_at":"2012-12-05T21:29:07.000Z","possibly_sensitive":false,"author_id":"69232855","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":11,"end":25,"username":"AB_CancerCPGs","id":"217172598"},{"start":39,"end":54,"username":"jaziehoncology","id":"396145125"},{"start":56,"end":64,"username":"mlazqui","id":"196132848"},{"start":66,"end":82,"username":"Annals_Oncology","id":"44614314"},{"start":84,"end":90,"username":"EORTC","id":"414752636"},{"start":92,"end":108,"username":"BKKommunikation","id":"123588756"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News moves step closer to proactive publication of #ctdata. Click to watch video or sign-up. http://t.co/pFA887CS http://t.co/pFA887CS","conversation_id":"276378186210750464","source":"Safari on iOS","id":"276378186210750464","created_at":"2012-12-05T17:31:09.000Z","possibly_sensitive":false,"author_id":"113148426","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":56,"end":63,"tag":"ctdata"}],"urls":[{"start":98,"end":118,"url":"http://t.co/pFA887CS","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2012/12/news_detail_001669.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"},{"start":119,"end":139,"url":"http://t.co/pFA887CS","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2012/12/news_detail_001669.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News consultation on the revised guideline on quality of #biosimilar medicines closes today | http://t.co/vTyDhGXN","conversation_id":"274490635287928832","source":"Twitter Web Client","id":"274490635287928832","created_at":"2012-11-30T12:30:41.000Z","possibly_sensitive":false,"author_id":"934944012","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":62,"end":73,"tag":"biosimilar"}],"urls":[{"start":99,"end":119,"url":"http://t.co/vTyDhGXN","expanded_url":"http://bit.ly/Xc5Fo7","display_url":"bit.ly/Xc5Fo7"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News #EMA provides plan to help deal with manufacturing-related medicine shortages http://t.co/qEy2IMLq","conversation_id":"274126215919575041","source":"Twitter Web Client","id":"274126215919575041","created_at":"2012-11-29T12:22:37.000Z","possibly_sensitive":false,"author_id":"523248351","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":14,"tag":"EMA"}],"urls":[{"start":88,"end":108,"url":"http://t.co/qEy2IMLq","expanded_url":"http://bit.ly/10YSIw4","display_url":"bit.ly/10YSIw4"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News @EU_eHealth @Masja_vh_Hoofd @Maltaparkinsons @c_rorato_UTIP @DocInsanity @LeandroRhein7 - Thanks for the re-tweets :)","conversation_id":"273750846691479552","source":"TweetDeck","id":"273750846691479552","created_at":"2012-11-28T11:31:02.000Z","possibly_sensitive":false,"author_id":"190227425","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":21,"username":"EU_eHealth","id":"931560712484343810"},{"start":22,"end":37,"username":"Masja_vh_Hoofd","id":"945566478"},{"start":38,"end":54,"username":"Maltaparkinsons","id":"859250042"},{"start":70,"end":82,"username":"DocInsanity","id":"2541996104"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News recommends new indic. for abiraterone in treatmt of metastatic castration resistant #prostate #cancer http://t.co/M9n90Cij","conversation_id":"273489311566004224","source":"Hootsuite","id":"273489311566004224","created_at":"2012-11-27T18:11:47.000Z","possibly_sensitive":false,"author_id":"69232855","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":94,"end":103,"tag":"prostate"},{"start":104,"end":111,"tag":"cancer"}],"urls":[{"start":112,"end":132,"url":"http://t.co/M9n90Cij","expanded_url":"http://ow.ly/fCsjQ","display_url":"ow.ly/fCsjQ"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Second time around! Didn't they withdraw the same applications back in 2008?","conversation_id":"273391454594940929","source":"Twitter Web Client","id":"273413110730199040","created_at":"2012-11-27T13:09:00.000Z","possibly_sensitive":false,"author_id":"576239908","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"273391454594940929"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News The EMA has published a plan to help deal with manufacturing-related medicine shortages | http://t.co/vTyDhGXN","conversation_id":"273407037600325633","source":"Twitter Web Client","id":"273407037600325633","created_at":"2012-11-27T12:44:52.000Z","possibly_sensitive":false,"author_id":"934944012","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":100,"end":120,"url":"http://t.co/vTyDhGXN","expanded_url":"http://bit.ly/Xc5Fo7","display_url":"bit.ly/Xc5Fo7"}],"annotations":[{"start":14,"end":16,"probability":0.4541,"type":"Organization","normalized_text":"EMA"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News published plan to help with medicine #shortages caused by #manufacturing problems: http://t.co/CboLXlKp #pharma #biotech","conversation_id":"273356316867698688","source":"Twitter for iPhone","id":"273356316867698688","created_at":"2012-11-27T09:23:19.000Z","possibly_sensitive":false,"author_id":"243228907","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":47,"end":57,"tag":"shortages"},{"start":68,"end":82,"tag":"manufacturing"},{"start":114,"end":121,"tag":"pharma"},{"start":122,"end":130,"tag":"biotech"}],"urls":[{"start":93,"end":113,"url":"http://t.co/CboLXlKp","expanded_url":"http://bit.ly/10YSIw3","display_url":"bit.ly/10YSIw3"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News @McDawg @EFPIA You've been quoted in my @Storify story: \"EMA workshop on sharing clinical trials data\" http://t.co/JHbfnzPu","conversation_id":"271766956833648640","source":"Storify on iOS","id":"271766956833648640","created_at":"2012-11-23T00:07:46.000Z","possibly_sensitive":false,"author_id":"16947313","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":17,"username":"McDawg","id":"12432262"},{"start":18,"end":24,"username":"EFPIA","id":"52084584"},{"start":50,"end":58,"username":"Storify","id":"17814938"}],"hashtags":{},"urls":[{"start":113,"end":133,"url":"http://t.co/JHbfnzPu","expanded_url":"http://sfy.co/nBrw","display_url":"sfy.co/nBrw"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News @trished Workshop on clinical-trial data and transparency  You've been quoted in my #Storify  #ctdata wrap up http://t.co/QHVK05vH","conversation_id":"271713809658421248","source":"Storify","id":"271713809658421248","created_at":"2012-11-22T20:36:35.000Z","possibly_sensitive":false,"author_id":"497691232","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":18,"username":"trished","id":"16947313"}],"hashtags":[{"start":94,"end":102,"tag":"Storify"},{"start":104,"end":111,"tag":"ctdata"}],"urls":[{"start":120,"end":140,"url":"http://t.co/QHVK05vH","expanded_url":"http://sfy.co/aBK7","display_url":"sfy.co/aBK7"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Thanks - and thank-you also for organising such an important meeting today #ctdata","conversation_id":"271672244097388544","source":"Twitter Web Client","id":"271673106446286848","created_at":"2012-11-22T17:54:50.000Z","possibly_sensitive":false,"author_id":"44984089","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":85,"end":92,"tag":"ctdata"}],"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"271672840351272960"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News \n“Missing data” in drug applications is morally and ethically not acceptable","conversation_id":"271665281200431104","source":"Twitter Web Client","id":"271665281200431104","created_at":"2012-11-22T17:23:44.000Z","possibly_sensitive":false,"author_id":"409118761","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News @bengoldacre What's to lose? Why won't pharma embrace mandatory disclosure of #ctdata? Scrip discussing here http://t.co/k4kEpY9W","conversation_id":"271652494810169345","source":"Twitter Web Client","id":"271652494810169345","created_at":"2012-11-22T16:32:56.000Z","possibly_sensitive":false,"author_id":"576239908","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":22,"username":"bengoldacre","id":"6705042"}],"hashtags":[{"start":88,"end":95,"tag":"ctdata"}],"urls":[{"start":119,"end":139,"url":"http://t.co/k4kEpY9W","expanded_url":"http://linkd.in/TTAMCV","display_url":"linkd.in/TTAMCV"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@ema_news \nwhat about integrity of data being maintained properly! data manipulation,once detached from the metadata is easy!","conversation_id":"271641660365090816","source":"Mobile Web","id":"271645076411789312","created_at":"2012-11-22T16:03:27.000Z","possibly_sensitive":false,"author_id":"964488271","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"271641660365090816"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@ema_news \nHow to ensure patients rights on revoking access and use of their data if the data go to many different places?","conversation_id":"271640951187988480","source":"Mobile Web","id":"271644530078531585","created_at":"2012-11-22T16:01:17.000Z","possibly_sensitive":false,"author_id":"964488271","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"271640951187988480"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"und","text":"@ema_news","conversation_id":"271640951187988480","source":"Mobile Web","id":"271643977386700800","created_at":"2012-11-22T15:59:05.000Z","possibly_sensitive":false,"author_id":"964488271","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"271640951187988480"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News In the case Pharma is going to pay for it then eventually the costs will trickle down to the patients #ctdata","conversation_id":"271636894939500544","source":"Twitter Web Client","id":"271638859828305920","created_at":"2012-11-22T15:38:45.000Z","possibly_sensitive":false,"author_id":"34232316","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":112,"end":119,"tag":"ctdata"}],"urls":{},"annotations":[{"start":22,"end":27,"probability":0.5119,"type":"Organization","normalized_text":"Pharma"}],"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"271636894939500544"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News yes, blame the media for not wanting to release info - but Pharma is happy to use media for their positive data stories...","conversation_id":"271626131814354944","source":"Twitter for iPhone","id":"271627809984770048","created_at":"2012-11-22T14:54:51.000Z","possibly_sensitive":false,"author_id":"104112634","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":[{"start":69,"end":74,"probability":0.564,"type":"Organization","normalized_text":"Pharma"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"271626131814354944"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":".@EMA_News - that makes more sense than letting any Tom, Dick or Harry look at the data","conversation_id":"271620940658511873","source":"Twitter Web Client","id":"271621155197173760","created_at":"2012-11-22T14:28:24.000Z","possibly_sensitive":false,"author_id":"100032683","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":1,"end":10,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":[{"start":52,"end":54,"probability":0.9881,"type":"Person","normalized_text":"Tom"},{"start":57,"end":60,"probability":0.7336,"type":"Person","normalized_text":"Dick"},{"start":65,"end":69,"probability":0.9943,"type":"Person","normalized_text":"Harry"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"271620940658511873"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News @bengoldacre Christ concentrate on what you are doing. You're like a footballer commentating on his own game!","conversation_id":"271617716484460544","source":"Twitter Web Client","id":"271619224940732416","created_at":"2012-11-22T14:20:44.000Z","possibly_sensitive":false,"author_id":"41341098","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":10,"end":22,"username":"bengoldacre","id":"6705042"}],"hashtags":{},"urls":{},"annotations":[{"start":23,"end":28,"probability":0.5662,"type":"Person","normalized_text":"Christ"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"271617716484460544"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News #ctdata livestream has given up. Just keep tweeting!","conversation_id":"271605891780972544","source":"Twitter Web Client","id":"271605891780972544","created_at":"2012-11-22T13:27:45.000Z","possibly_sensitive":false,"author_id":"435091401","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":17,"tag":"ctdata"}],"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Workshop is broadcasting ;o) #ctdata","conversation_id":"271598669529219072","source":"TweetDeck","id":"271598669529219072","created_at":"2012-11-22T12:59:03.000Z","possibly_sensitive":false,"author_id":"114429252","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":39,"end":46,"tag":"ctdata"}],"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News great choice of music pre #workshop Relishing the opportunity to have a little boogie at my desk #ctdata","conversation_id":"271597415667204097","source":"Twitter Web Client","id":"271597415667204097","created_at":"2012-11-22T12:54:04.000Z","possibly_sensitive":false,"author_id":"435091401","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":36,"end":45,"tag":"workshop"},{"start":107,"end":114,"tag":"ctdata"}],"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News #ctdata begins at 2PM Brussels time, right?","conversation_id":"271569444755632128","source":"TweetDeck","id":"271571377125998592","created_at":"2012-11-22T11:10:36.000Z","possibly_sensitive":false,"author_id":"114429252","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":17,"tag":"ctdata"}],"urls":{},"annotations":[{"start":32,"end":39,"probability":0.3479,"type":"Place","normalized_text":"Brussels"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"271569444755632128"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"fr","text":"@EMA_News Excellent news! cc @GundiGadesmann @quarsan @Fergal_O_Regan #ctdata","conversation_id":"270497173018378240","source":"TweetDeck","id":"270819262434783232","created_at":"2012-11-20T09:21:58.000Z","possibly_sensitive":false,"author_id":"114429252","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":29,"end":44,"username":"GundiGadesmann","id":"412174660"},{"start":45,"end":53,"username":"quarsan","id":"17508218"}],"hashtags":[{"start":70,"end":77,"tag":"ctdata"}],"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"270497173018378240"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News #workshop on #clinicaltrial #data &amp; #transparency is in 3 days http://t.co/bJOc9OqQ #ctdata http://t.co/JHUbL5AG #biotech #pharma","conversation_id":"270461975220330496","source":"Twitter for iPhone","id":"270461975220330496","created_at":"2012-11-19T09:42:14.000Z","possibly_sensitive":false,"author_id":"243228907","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":19,"tag":"workshop"},{"start":23,"end":37,"tag":"clinicaltrial"},{"start":38,"end":43,"tag":"data"},{"start":50,"end":63,"tag":"transparency"},{"start":98,"end":105,"tag":"ctdata"},{"start":127,"end":135,"tag":"biotech"},{"start":136,"end":143,"tag":"pharma"}],"urls":[{"start":77,"end":97,"url":"http://t.co/bJOc9OqQ","expanded_url":"http://bit.ly/W95h3A","display_url":"bit.ly/W95h3A"},{"start":106,"end":126,"url":"http://t.co/JHUbL5AG","expanded_url":"http://bit.ly/O2P7b1","display_url":"bit.ly/O2P7b1"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News #CHMP gives go ahead for @Novartis #meningitis B #vaccine Bexsero for prevention of bacterial meningitis caused by N. meningitidis","conversation_id":"269528983186591746","source":"Twitter for iPhone","id":"269528983186591746","created_at":"2012-11-16T19:54:51.000Z","possibly_sensitive":false,"author_id":"243228907","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":35,"end":44,"username":"Novartis","id":"17226612"}],"hashtags":[{"start":10,"end":15,"tag":"CHMP"},{"start":45,"end":56,"tag":"meningitis"},{"start":59,"end":67,"tag":"vaccine"}],"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News, @BreastOncology, @CAPhO_ACPhO, @MOGA_ORG, @FarmaOnco, @BKKommunikation @lucasmalki, @mustafa63325636 Tx for yr RTs/MTs","conversation_id":"269183343319449600","source":"Hootsuite","id":"269183343319449600","created_at":"2012-11-15T21:01:24.000Z","possibly_sensitive":false,"author_id":"69232855","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":11,"end":26,"username":"BreastOncology","id":"719804523208974336"},{"start":28,"end":40,"username":"CAPhO_ACPhO","id":"355636558"},{"start":42,"end":51,"username":"MOGA_ORG","id":"364615723"},{"start":53,"end":63,"username":"FarmaOnco","id":"917639060"},{"start":65,"end":81,"username":"BKKommunikation","id":"123588756"},{"start":82,"end":93,"username":"lucasmalki","id":"288682290"},{"start":95,"end":111,"username":"mustafa63325636","id":"714362456"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News great. Thanks. Looking forward to it!:)","conversation_id":"269047857372352512","source":"Twitter Web Client","id":"269051148672069632","created_at":"2012-11-15T12:16:07.000Z","possibly_sensitive":false,"author_id":"40722651","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"269050890374217731"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News cool. Will it be webcasted?","conversation_id":"269047857372352512","source":"Twitter Web Client","id":"269050481555427328","created_at":"2012-11-15T12:13:28.000Z","possibly_sensitive":false,"author_id":"40722651","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"269047857372352512"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Thanks for all the re-tweets, always appreciated :)","conversation_id":"268716342729928704","source":"Twitter for iPhone","id":"268716342729928704","created_at":"2012-11-14T14:05:43.000Z","possibly_sensitive":false,"author_id":"190227425","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@ema_news Will do. Thank you.","conversation_id":"266313452438560768","source":"Hootsuite","id":"266479762158022656","created_at":"2012-11-08T09:58:20.000Z","possibly_sensitive":false,"author_id":"420457218","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"266471773745324033"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Thank you for the RT, hope to have you join us later today for our #FLUchat!","conversation_id":"263939560449396736","source":"Twitter Web Client","id":"263939560449396736","created_at":"2012-11-01T09:44:29.000Z","possibly_sensitive":false,"author_id":"125403342","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":77,"end":85,"tag":"FLUchat"}],"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News, @AB_CancerCPGs, @oncology23, @BreastOncology, @mtmdphd, @drdonsdizon, @dkgweb, @jessicawapner, @danypas Tx for RTs/MTs!","conversation_id":"262276802519658496","source":"Hootsuite","id":"262276802519658496","created_at":"2012-10-27T19:37:17.000Z","possibly_sensitive":false,"author_id":"69232855","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":11,"end":25,"username":"AB_CancerCPGs","id":"217172598"},{"start":27,"end":38,"username":"oncology23","id":"125456212"},{"start":40,"end":55,"username":"BreastOncology","id":"719804523208974336"},{"start":57,"end":65,"username":"mtmdphd","id":"190337035"},{"start":67,"end":79,"username":"drdonsdizon","id":"572062434"},{"start":90,"end":104,"username":"jessicawapner","id":"265705352"},{"start":106,"end":114,"username":"danypas","id":"62370533"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News: Thanks for the re-tweets :)","conversation_id":"260723400710959105","source":"TweetDeck","id":"260723400710959105","created_at":"2012-10-23T12:44:37.000Z","possibly_sensitive":false,"author_id":"190227425","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Bagels for lunch this week?? Your Canary Wharf, London employees can get 10% off now! Coupon SHOP10 at http://t.co/7J2b6CpK!","conversation_id":"260390053593890816","source":"Twitter Web Client","id":"260390053593890816","created_at":"2012-10-22T14:40:01.000Z","possibly_sensitive":false,"author_id":"562385501","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":113,"end":133,"url":"http://t.co/7J2b6CpK","expanded_url":"http://canarywharfbagels.com","display_url":"canarywharfbagels.com"}],"annotations":[{"start":44,"end":55,"probability":0.321,"type":"Place","normalized_text":"Canary Wharf"},{"start":58,"end":63,"probability":0.7281,"type":"Place","normalized_text":"London"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"no","text":"@EMA_News bekrefter at #diclofenac giver en lett økt risiko for hjertekarsykdom #NSAID http://t.co/niol331U","conversation_id":"260358160156606464","source":"Twitter for iPad","id":"260358160156606464","created_at":"2012-10-22T12:33:17.000Z","possibly_sensitive":false,"author_id":"37982988","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":23,"end":34,"tag":"diclofenac"},{"start":80,"end":86,"tag":"NSAID"}],"urls":[{"start":87,"end":107,"url":"http://t.co/niol331U","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2012/10/news_detail_001637.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"place_id":"e42ed02b50d62e29","coordinates":{"type":"Point","coordinates":[10.7349,59.9177]}}},{"lang":"en","text":"@EMA_News, @BrandcastHealth, @datacision, @lucidaMC, @BKKommunikation, @katseyemedia, @OttawaCoP, @incrowdnow tx for yr RTs/MTs!","conversation_id":"260348894561574912","source":"Hootsuite","id":"260348894561574912","created_at":"2012-10-22T11:56:28.000Z","possibly_sensitive":false,"author_id":"69232855","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":11,"end":27,"username":"BrandcastHealth","id":"2306341848"},{"start":29,"end":40,"username":"datacision","id":"129210781"},{"start":42,"end":51,"username":"lucidaMC","id":"239863785"},{"start":53,"end":69,"username":"BKKommunikation","id":"123588756"},{"start":71,"end":84,"username":"katseyemedia","id":"237441463"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News #CHMP backs #Tresiba and #Ryzodeg from #NovoNordisk in #diabetes; 2017 sales of $2.27bn &amp; $417M, respectively says #Datamonitor","conversation_id":"259585949581860864","source":"Twitter for iPhone","id":"259585949581860864","created_at":"2012-10-20T09:24:47.000Z","possibly_sensitive":false,"author_id":"243228907","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":15,"tag":"CHMP"},{"start":22,"end":30,"tag":"Tresiba"},{"start":35,"end":43,"tag":"Ryzodeg"},{"start":49,"end":61,"tag":"NovoNordisk"},{"start":65,"end":74,"tag":"diabetes"},{"start":129,"end":141,"tag":"Datamonitor"}],"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@ema_news Here is the beginning of the patient group's response to your news on #Pandemrix &amp; development of #narcolepsy http://t.co/p5KLSbBi","conversation_id":"259278507169951744","source":"Hootsuite","id":"259302142131724288","created_at":"2012-10-19T14:37:02.000Z","possibly_sensitive":false,"author_id":"320293216","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":80,"end":90,"tag":"Pandemrix"},{"start":112,"end":123,"tag":"narcolepsy"}],"urls":[{"start":124,"end":144,"url":"http://t.co/p5KLSbBi","expanded_url":"http://bit.ly/TxTsSt","display_url":"bit.ly/TxTsSt"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"259278507169951744"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News reports a fall in generic applications this year so far http://t.co/OeYTc0tf","conversation_id":"259300806031966208","source":"Hootsuite","id":"259300806031966208","created_at":"2012-10-19T14:31:44.000Z","possibly_sensitive":false,"author_id":"197435213","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":66,"end":86,"url":"http://t.co/OeYTc0tf","expanded_url":"http://ow.ly/eBtbA","display_url":"ow.ly/eBtbA"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Thanks for the re-tweet :)","conversation_id":"259061490798190594","source":"Twitter Web Client","id":"259061490798190594","created_at":"2012-10-18T22:40:47.000Z","possibly_sensitive":false,"author_id":"190227425","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Where’s the information on adverse effects? http://t.co/Zx0msaHg … …","conversation_id":"257844586444115969","source":"Twitter Web Client","id":"257844586444115969","created_at":"2012-10-15T14:05:14.000Z","possibly_sensitive":false,"author_id":"439533490","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":54,"end":74,"url":"http://t.co/Zx0msaHg","expanded_url":"http://www.veterinaryprescriber.org/blog/2012/10/4/wheres-the-information-on-adverse-effects.html","display_url":"veterinaryprescriber.org/blog/2012/10/4…"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News stats underpin why #pharma &amp; #biotech should take regulatory advice they asked for as it increases chances of approval @scripnews","conversation_id":"256713057147965440","source":"Twitter for iPhone","id":"256713057147965440","created_at":"2012-10-12T11:08:56.000Z","possibly_sensitive":false,"author_id":"243228907","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":29,"end":36,"tag":"pharma"},{"start":43,"end":51,"tag":"biotech"}],"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News congrats!:)","conversation_id":"256697244256976896","source":"Twitter Web Client","id":"256697606426726400","created_at":"2012-10-12T10:07:33.000Z","possibly_sensitive":false,"author_id":"40722651","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"256697244256976896"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Recognition of our conflict of interest handling by European Court of Auditors, with room to do even more http://t.co/9Bf1SFYo","conversation_id":"256386709212762112","source":"bitly bitlink","id":"256386709212762112","created_at":"2012-10-11T13:32:09.000Z","possibly_sensitive":false,"author_id":"116716199","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":116,"end":136,"url":"http://t.co/9Bf1SFYo","expanded_url":"http://bit.ly/SNOncr","display_url":"bit.ly/SNOncr"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News EMA commitment to transparency means much more information on safety reviews. See October 2012 PRAC outcome http://t.co/3thebkdS","conversation_id":"254245335747153920","source":"Twitter for iPad","id":"254245335747153920","created_at":"2012-10-05T15:43:06.000Z","possibly_sensitive":false,"author_id":"116716199","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":118,"end":138,"url":"http://t.co/3thebkdS","expanded_url":"http://bit.ly/QXj928","display_url":"bit.ly/QXj928"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News First list published of active substances with lead Member State responsible for monitoring safety data http://t.co/qhdBA0Jd","conversation_id":"254243434871799808","source":"Twitter for iPad","id":"254243434871799808","created_at":"2012-10-05T15:35:33.000Z","possibly_sensitive":false,"author_id":"116716199","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":114,"end":134,"url":"http://t.co/qhdBA0Jd","expanded_url":"http://bit.ly/QP0QJ9","display_url":"bit.ly/QP0QJ9"}],"annotations":[{"start":62,"end":73,"probability":0.5287,"type":"Organization","normalized_text":"Member State"}],"cashtags":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Outcome of October 2012 PRAC published. First safety review begun. http://t.co/MO5TbGJX","conversation_id":"254186060286926848","source":"Safari on iOS","id":"254186060286926848","created_at":"2012-10-05T11:47:33.000Z","possibly_sensitive":false,"author_id":"116716199","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":77,"end":97,"url":"http://t.co/MO5TbGJX","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2012/10/news_detail_001623.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News #EMA publishes list of EU reference dates and frequency of PSUR submission http://t.co/EAv6ExLH","conversation_id":"253035722729197568","source":"Twitter Web Client","id":"253035722729197568","created_at":"2012-10-02T07:36:32.000Z","possibly_sensitive":false,"author_id":"523248351","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":10,"end":14,"tag":"EMA"}],"urls":[{"start":85,"end":105,"url":"http://t.co/EAv6ExLH","expanded_url":"http://bit.ly/Sh2IQq","display_url":"bit.ly/Sh2IQq"}],"annotations":[{"start":33,"end":34,"probability":0.5816,"type":"Organization","normalized_text":"EU"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Ex-EU ref prods allow developers to leverage global programs. Unclear if FDA will follow, but close collab with EMA. #biosimilars","conversation_id":"252712840203468801","source":"Twitter Web Client","id":"252712840203468801","created_at":"2012-10-01T10:13:30.000Z","possibly_sensitive":false,"author_id":"595302998","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":127,"end":139,"tag":"biosimilars"}],"urls":{},"annotations":[{"start":83,"end":85,"probability":0.8777,"type":"Organization","normalized_text":"FDA"}],"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Many RoW biologics same source as in EU. Justifying non-EU ref product will often be no problem for #biosimilars","conversation_id":"252712480382545920","source":"Twitter Web Client","id":"252712480382545920","created_at":"2012-10-01T10:12:05.000Z","possibly_sensitive":false,"author_id":"595302998","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":110,"end":122,"tag":"biosimilars"}],"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"cs","text":"@EMA_News Frее iРhоne 5 gift саrd http://t.co/RjKOrNHE","conversation_id":"251669832293023744","source":"Mobile Web","id":"251669832293023744","created_at":"2012-09-28T13:08:58.000Z","possibly_sensitive":false,"author_id":"563607955","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":34,"end":54,"url":"http://t.co/RjKOrNHE","expanded_url":"http://is.gd/L2CiEa","display_url":"is.gd/L2CiEa"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News I cannot get pass the paywall from here, I regret to tell you. Have you tried?","conversation_id":"251238922150088704","source":"Twitter Web Client","id":"251614245672845313","created_at":"2012-09-28T09:28:05.000Z","possibly_sensitive":false,"author_id":"60826646","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"251307962377834496"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Please explain how taxpayers can access this article for free http://t.co/QrsHNDO9","conversation_id":"251238922150088704","source":"Twitter Web Client","id":"251364105884151808","created_at":"2012-09-27T16:54:07.000Z","possibly_sensitive":false,"author_id":"60826646","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":72,"end":92,"url":"http://t.co/QrsHNDO9","expanded_url":"http://bit.ly/P8eeac","display_url":"bit.ly/P8eeac"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"251307962377834496"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News, @3NT, @henryevrh, @ompdigital, @rabannister, @oncorosell, @GroupeUNICANCER, @BreastOncology, @EORTC thank U for RTs/MTs","conversation_id":"251231530758856704","source":"Hootsuite","id":"251231530758856704","created_at":"2012-09-27T08:07:19.000Z","possibly_sensitive":false,"author_id":"69232855","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":11,"end":15,"username":"3NT","id":"228845995"},{"start":29,"end":40,"username":"OMPDigital","id":"40100961"},{"start":56,"end":67,"username":"oncorosell","id":"296904185"},{"start":69,"end":85,"username":"GroupeUNICANCER","id":"289876859"},{"start":87,"end":102,"username":"BreastOncology","id":"719804523208974336"},{"start":104,"end":110,"username":"EORTC","id":"414752636"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Committee for Advanced Therapies' activities streamlined http://t.co/yrprQtLl","conversation_id":"250548234412503041","source":"Twitter Web Client","id":"250548234412503041","created_at":"2012-09-25T10:52:08.000Z","possibly_sensitive":false,"author_id":"523248351","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":67,"end":87,"url":"http://t.co/yrprQtLl","expanded_url":"http://bit.ly/UKU5MG","display_url":"bit.ly/UKU5MG"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News publishes meeting highlights from #CHMP http://t.co/dP8Fw7FU","conversation_id":"250165360316252160","source":"Twitter Web Client","id":"250165360316252160","created_at":"2012-09-24T09:30:44.000Z","possibly_sensitive":false,"author_id":"523248351","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":44,"end":49,"tag":"CHMP"}],"urls":[{"start":50,"end":70,"url":"http://t.co/dP8Fw7FU","expanded_url":"http://bit.ly/Se50yW","display_url":"bit.ly/Se50yW"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News CHMP recommends EU approval for $REGN and @Bayer #HealthCare potential blockbuster #Eylea in wet AMD #pharma #biotech","conversation_id":"249166447111184384","source":"Twitter for iPhone","id":"249166447111184384","created_at":"2012-09-21T15:21:24.000Z","possibly_sensitive":false,"author_id":"243228907","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":52,"end":58,"username":"Bayer","id":"137319302"}],"hashtags":[{"start":59,"end":70,"tag":"HealthCare"},{"start":93,"end":99,"tag":"Eylea"},{"start":111,"end":118,"tag":"pharma"},{"start":119,"end":127,"tag":"biotech"}],"urls":{},"annotations":{},"cashtags":[{"start":42,"end":47,"tag":"REGN"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News I like your SME initiative &amp; the success of 1000 registrations! offer additional value services from @invapay http://t.co/qEM8VCrA","conversation_id":"248706531200204800","source":"Twitter Web Client","id":"248706531200204800","created_at":"2012-09-20T08:53:52.000Z","possibly_sensitive":false,"author_id":"241130094","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":115,"end":123,"username":"Invapay","id":"1073251289885233152"}],"hashtags":{},"urls":[{"start":124,"end":144,"url":"http://t.co/qEM8VCrA","expanded_url":"http://invapay.com","display_url":"invapay.com"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News do you like this phot0 ? - http://t.co/B0LOoVHv","conversation_id":"248352413105418240","source":"Twitter Web Client","id":"248352413105418240","created_at":"2012-09-19T09:26:44.000Z","possibly_sensitive":false,"author_id":"252746255","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":37,"end":57,"url":"http://t.co/B0LOoVHv","expanded_url":"http://ispy.it/14o7","display_url":"ispy.it/14o7"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News releases list of #research needs in children’s medicines - highlighting to pharma gaps in #R&amp;D\nhttp://t.co/IkAkEXmK","conversation_id":"245168719742005248","source":"TweetDeck","id":"245168719742005248","created_at":"2012-09-10T14:35:52.000Z","possibly_sensitive":false,"author_id":"239383823","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":27,"end":36,"tag":"research"},{"start":100,"end":102,"tag":"R"}],"urls":[{"start":109,"end":129,"url":"http://t.co/IkAkEXmK","expanded_url":"http://www.pmlive.com/pharma_news/ema_publishes_list_of_research_needs_for_childrens_cardiovascular_medicines_423697","display_url":"pmlive.com/pharma_news/em…"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News thanks! I'll send an email hoping you can help me.","conversation_id":"242718923018100737","source":"Twitter for iPhone","id":"242937825174114305","created_at":"2012-09-04T10:51:05.000Z","possibly_sensitive":false,"author_id":"31437646","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"242907085992521728"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News is there a decision of the CMVP regarding MRL for fenbendazole in poultry? Or does it stay as the summary opinion of Dec 09, 2012?","conversation_id":"242718923018100737","source":"TweetDeck","id":"242718923018100737","created_at":"2012-09-03T20:21:15.000Z","possibly_sensitive":false,"author_id":"31437646","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":[{"start":37,"end":40,"probability":0.4279,"type":"Organization","normalized_text":"CMVP"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News How do you decide what to ReTweet?","conversation_id":"237568177805086720","source":"Twitter Web Client","id":"237568177805086720","created_at":"2012-08-20T15:14:02.000Z","possibly_sensitive":false,"author_id":"40722651","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News ► European Medicines Agency consultation on good  #pharmacovigilance practice (GVP) modules: http://t.co/otqbrC2k @EU_Consumer","conversation_id":"233470424887988224","source":"Twitter Web Client","id":"233470424887988224","created_at":"2012-08-09T07:51:01.000Z","possibly_sensitive":false,"author_id":"184756856","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":124,"end":136,"username":"EU_Consumer","id":"39516018"}],"hashtags":[{"start":60,"end":78,"tag":"pharmacovigilance"}],"urls":[{"start":103,"end":123,"url":"http://t.co/otqbrC2k","expanded_url":"http://bit.ly/O6c4tm","display_url":"bit.ly/O6c4tm"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News publishes public assessment reports for ancillary medicinal substances included in medical devices http://t.co/bIY3bRXa","conversation_id":"233189254958837761","source":"Twitter for Websites","id":"233189254958837761","created_at":"2012-08-08T13:13:45.000Z","possibly_sensitive":false,"author_id":"370067163","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":109,"end":129,"url":"http://t.co/bIY3bRXa","expanded_url":"http://goo.gl/zyeLs","display_url":"goo.gl/zyeLs"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News reminds marketing authorisation holders of more changes this month as part of phasing out follow up measures  http://t.co/DCqeZu1P","conversation_id":"231027046082543616","source":"Hootsuite","id":"231027046082543616","created_at":"2012-08-02T14:01:54.000Z","possibly_sensitive":false,"author_id":"197435213","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":120,"end":140,"url":"http://t.co/DCqeZu1P","expanded_url":"http://ow.ly/cGlTO","display_url":"ow.ly/cGlTO"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News *yawn* what else is new?","conversation_id":"230996934373019649","source":"Twitter Web Client","id":"230997671257702401","created_at":"2012-08-02T12:05:11.000Z","possibly_sensitive":false,"author_id":"40722651","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"230996934373019649"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News EMA have increased their interactions with medicines regulators in #Japan over the past three years: http://t.co/WIjnSFAo","conversation_id":"230294628270755840","source":"Twitter Web Client","id":"230294628270755840","created_at":"2012-07-31T13:31:32.000Z","possibly_sensitive":false,"author_id":"418827307","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":77,"end":83,"tag":"Japan"}],"urls":[{"start":111,"end":131,"url":"http://t.co/WIjnSFAo","expanded_url":"http://bit.ly/ObLP67","display_url":"bit.ly/ObLP67"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News no pictures? You really can not have \"incrased interaction\" with the Japanese without posting pictures of it.","conversation_id":"230222958394748928","source":"Twitter Web Client","id":"230224424501121024","created_at":"2012-07-31T08:52:34.000Z","possibly_sensitive":false,"author_id":"40722651","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"230222958394748928"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News smart move.","conversation_id":"230222958394748928","source":"Twitter Web Client","id":"230223547614773248","created_at":"2012-07-31T08:49:05.000Z","possibly_sensitive":false,"author_id":"40722651","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"230222958394748928"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Certainly.  Thanks for the very speedy reponse.","conversation_id":"229874809507565568","source":"Twitter Web Client","id":"229880413051559936","created_at":"2012-07-30T10:05:36.000Z","possibly_sensitive":false,"author_id":"372715566","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"229879329272770561"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Is there any data on pharmacovigilance studies in Japan done by Japanese companies compared to global pharma conducted in Japan?","conversation_id":"229874809507565568","source":"Twitter Web Client","id":"229878961352605696","created_at":"2012-07-30T09:59:49.000Z","possibly_sensitive":false,"author_id":"372715566","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":[{"start":60,"end":64,"probability":0.988,"type":"Place","normalized_text":"Japan"},{"start":132,"end":136,"probability":0.9829,"type":"Place","normalized_text":"Japan"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"229874809507565568"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News thanks! i'll consider it today","conversation_id":"228529528216117248","source":"TweetDeck","id":"228816964926177280","created_at":"2012-07-27T11:39:50.000Z","possibly_sensitive":false,"author_id":"31437646","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"228762875588665345"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News EMA bids farewell to CHMP Pharmacovigilance Working Party http://t.co/NekOrduH","conversation_id":"228754228892549120","source":"Twitter Web Client","id":"228754228892549120","created_at":"2012-07-27T07:30:32.000Z","possibly_sensitive":false,"author_id":"523248351","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":68,"end":88,"url":"http://t.co/NekOrduH","expanded_url":"http://bit.ly/NM1kA8","display_url":"bit.ly/NM1kA8"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News 20.00 to 24.00 London hour?","conversation_id":"228529528216117248","source":"TweetDeck","id":"228530423221862400","created_at":"2012-07-26T16:41:13.000Z","possibly_sensitive":false,"author_id":"31437646","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":[{"start":25,"end":30,"probability":0.8304,"type":"Place","normalized_text":"London"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"228529528216117248"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News recommends #Glybera for approval. 1st recommendation ever for #gen-#therapy-#drug in #western #world! http://t.co/pZJlBw5O","conversation_id":"228530111194988544","source":"TweetDeck","id":"228530111194988544","created_at":"2012-07-26T16:39:59.000Z","possibly_sensitive":false,"author_id":"587397928","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":21,"end":29,"tag":"Glybera"},{"start":72,"end":76,"tag":"gen"},{"start":77,"end":85,"tag":"therapy"},{"start":86,"end":91,"tag":"drug"},{"start":95,"end":103,"tag":"western"},{"start":104,"end":110,"tag":"world"}],"urls":[{"start":112,"end":132,"url":"http://t.co/pZJlBw5O","expanded_url":"http://bit.ly/NNnfsY","display_url":"bit.ly/NNnfsY"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News published its 2011 report of activities in the area of medicines for children #paediatric #EU http://t.co/vIHGi1Nn","conversation_id":"228431251147743232","source":"Twitter Web Client","id":"228431251147743232","created_at":"2012-07-26T10:07:08.000Z","possibly_sensitive":false,"author_id":"606325697","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":88,"end":99,"tag":"paediatric"},{"start":100,"end":103,"tag":"EU"}],"urls":[{"start":104,"end":124,"url":"http://t.co/vIHGi1Nn","expanded_url":"http://bit.ly/MWfJHL","display_url":"bit.ly/MWfJHL"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Exec Director visits BEUC. Robust approach to conflicts of interests &amp; transparency on right track. BEUC supports further efforts.","conversation_id":"226304147874525186","source":"Twitter Web Client","id":"226304147874525186","created_at":"2012-07-20T13:14:48.000Z","possibly_sensitive":false,"author_id":"237222584","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News launches #consultation on #pharmacovigilance changes to product information - http://t.co/7zl5pZxp","conversation_id":"225590071632465920","source":"Twitter Web Client","id":"225590071632465920","created_at":"2012-07-18T13:57:18.000Z","possibly_sensitive":false,"author_id":"523248351","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":19,"end":32,"tag":"consultation"},{"start":36,"end":54,"tag":"pharmacovigilance"}],"urls":[{"start":88,"end":108,"url":"http://t.co/7zl5pZxp","expanded_url":"http://bit.ly/Oj80GC","display_url":"bit.ly/Oj80GC"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Social Media Marketing Strategy http://t.co/L0rNB5Iy #retweet #socialmedia","conversation_id":"224840635969056769","source":"Twitter Web Client","id":"224841296060227587","created_at":"2012-07-16T12:21:56.000Z","possibly_sensitive":false,"author_id":"153340269","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":63,"end":71,"tag":"retweet"},{"start":72,"end":84,"tag":"socialmedia"}],"urls":[{"start":42,"end":62,"url":"http://t.co/L0rNB5Iy","expanded_url":"http://rajbgm.wordpress.com/2012/07/16/social-media-marketing-strategy","display_url":"rajbgm.wordpress.com/2012/07/16/soc…"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"224840635969056769"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"EMA's (non)response to TBCAB letter re DDI studies for #bedaquiline &amp; #delamanid : http://t.co/SDGHgDeI #MDR#TB\n@EMA_News","conversation_id":"223132303407333378","source":"Twitter Web Client","id":"223132303407333378","created_at":"2012-07-11T19:11:01.000Z","possibly_sensitive":false,"author_id":"313220925","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":116,"end":125,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":55,"end":67,"tag":"bedaquiline"},{"start":74,"end":84,"tag":"delamanid"}],"urls":[{"start":87,"end":107,"url":"http://t.co/SDGHgDeI","expanded_url":"http://goo.gl/d4m9P","display_url":"goo.gl/d4m9P"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"place_id":"c1430b24da8e9229","coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News strenghtened pharmacovigilance rules in place: safer medicines for European consumers. http://t.co/IfYoYkoj","conversation_id":"220182642979651586","source":"Twitter Web Client","id":"220182642979651586","created_at":"2012-07-03T15:50:07.000Z","possibly_sensitive":false,"author_id":"237222584","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":97,"end":117,"url":"http://t.co/IfYoYkoj","expanded_url":"http://qckns.tk","display_url":"qckns.tk"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Thanks for the retweet!","conversation_id":"219827628457205761","source":"TweetDeck","id":"220071938297569280","created_at":"2012-07-03T08:30:13.000Z","possibly_sensitive":false,"author_id":"140344419","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"219827628457205761"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News released yesterday two more modules on good #pharmacovigilance practice (#GVP) for public consultation: http://t.co/FHcZB55Q","conversation_id":"218285580323274752","source":"Twitter Web Client","id":"218285580323274752","created_at":"2012-06-28T10:11:52.000Z","possibly_sensitive":false,"author_id":"606325697","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":54,"end":72,"tag":"pharmacovigilance"},{"start":83,"end":87,"tag":"GVP"}],"urls":[{"start":114,"end":134,"url":"http://t.co/FHcZB55Q","expanded_url":"http://bit.ly/MA6WOq","display_url":"bit.ly/MA6WOq"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Visit http://t.co/iiNHo5X1 Top tips for #SocialMedia #Marketing #retweet","conversation_id":"217292672904331264","source":"Twitter Web Client","id":"217963133510225924","created_at":"2012-06-27T12:50:35.000Z","possibly_sensitive":false,"author_id":"153340269","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":50,"end":62,"tag":"SocialMedia"},{"start":63,"end":73,"tag":"Marketing"},{"start":74,"end":82,"tag":"retweet"}],"urls":[{"start":16,"end":36,"url":"http://t.co/iiNHo5X1","expanded_url":"http://rajbgm.wordpress.com/","display_url":"rajbgm.wordpress.com"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"217292672904331264"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News finalised the first set of modules on good #pharmacovigilance practices (#GVP): http://t.co/VeAxnQuK","conversation_id":"217548769040936960","source":"Twitter Web Client","id":"217548769040936960","created_at":"2012-06-26T09:24:03.000Z","possibly_sensitive":false,"author_id":"606325697","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":53,"end":71,"tag":"pharmacovigilance"},{"start":83,"end":87,"tag":"GVP"}],"urls":[{"start":90,"end":110,"url":"http://t.co/VeAxnQuK","expanded_url":"http://bit.ly/MnyANu","display_url":"bit.ly/MnyANu"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"fr","text":"RT @EMA_News Disponible en Français aussi  la nouvelle base de données européenne des effets indésirables http://t.co/D2xGKfdN","conversation_id":"215028036339372032","source":"Twitter Web Client","id":"215031755181273088","created_at":"2012-06-19T10:42:20.000Z","possibly_sensitive":false,"author_id":"134450541","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":106,"end":126,"url":"http://t.co/D2xGKfdN","expanded_url":"http://bit.ly/KNe7Qg","display_url":"bit.ly/KNe7Qg"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"215028036339372032"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News publishes guidance on developing medicines containing monoclonal antibodies, including biosimilars: http://t.co/V71oF6tm","conversation_id":"213683071902420994","source":"Twitter for BlackBerry®","id":"213683071902420994","created_at":"2012-06-15T17:23:09.000Z","possibly_sensitive":false,"author_id":"154118787","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":110,"end":130,"url":"http://t.co/V71oF6tm","expanded_url":"http://bit.ly/Lg5bXG","display_url":"bit.ly/Lg5bXG"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News boosts transparency with online publication of side effect reports http://t.co/afstqcKp","conversation_id":"208150891755343874","source":"Twitter Web Client","id":"208150891755343874","created_at":"2012-05-31T11:00:14.000Z","possibly_sensitive":false,"author_id":"237222584","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":77,"end":97,"url":"http://t.co/afstqcKp","expanded_url":"http://tiny.cc/q555ew","display_url":"tiny.cc/q555ew"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News has published reports of suspected side effects for medicines in EEA on new website http://t.co/BjNaPBCd #medical #pediatrics","conversation_id":"208141395461029890","source":"TweetDeck","id":"208141395461029890","created_at":"2012-05-31T10:22:30.000Z","possibly_sensitive":false,"author_id":"581955527","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":115,"end":123,"tag":"medical"},{"start":124,"end":135,"tag":"pediatrics"}],"urls":[{"start":94,"end":114,"url":"http://t.co/BjNaPBCd","expanded_url":"http://bit.ly/NilDUM","display_url":"bit.ly/NilDUM"}],"annotations":[{"start":75,"end":77,"probability":0.3323,"type":"Organization","normalized_text":"EEA"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Attending the European Medicines Agency workshop on Correlates for protection and serological assays for influenza vaccines","conversation_id":"207730873049681920","source":"Twitter for iPhone","id":"207730873049681920","created_at":"2012-05-30T07:11:14.000Z","possibly_sensitive":false,"author_id":"518659141","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Thank you for following! Heard about Waving for World Arthritis Day? Fun, easy to share &amp; take part! http://t.co/3C4sEoZO","conversation_id":"206688025479090176","source":"Twitter Web Client","id":"206688025479090176","created_at":"2012-05-27T10:07:20.000Z","possibly_sensitive":false,"author_id":"302074272","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":115,"end":135,"url":"http://t.co/3C4sEoZO","expanded_url":"http://tinyurl.com/cvza7v9","display_url":"tinyurl.com/cvza7v9"}],"annotations":[{"start":58,"end":76,"probability":0.6177,"type":"Other","normalized_text":"World Arthritis Day"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News recommends Kalydeco for the treatment of #CysticFibrosis  http://t.co/69MbfEa7 #rarediseases","conversation_id":"206059841473613824","source":"TweetDeck","id":"206059841473613824","created_at":"2012-05-25T16:31:09.000Z","possibly_sensitive":false,"author_id":"581955527","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":51,"end":66,"tag":"CysticFibrosis"},{"start":89,"end":102,"tag":"rarediseases"}],"urls":[{"start":68,"end":88,"url":"http://t.co/69MbfEa7","expanded_url":"http://bit.ly/KLDQsf","display_url":"bit.ly/KLDQsf"}],"annotations":[{"start":21,"end":28,"probability":0.4784,"type":"Person","normalized_text":"Kalydeco"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Bilateral meeting - between Director of EMA and President of the Office http://t.co/mVj1zqq9","conversation_id":"200634517504000000","source":"Twitter Web Client","id":"200634517504000000","created_at":"2012-05-10T17:12:51.000Z","possibly_sensitive":false,"author_id":"556859372","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":82,"end":102,"url":"http://t.co/mVj1zqq9","expanded_url":"http://instagr.am/p/KcBZGBuPUB/","display_url":"instagr.am/p/KcBZGBuPUB/"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Prof. Guido Rasi Executive Director of EMA has just started his visit in Poland http://t.co/MbDQjK5q","conversation_id":"200632438848897024","source":"Twitter Web Client","id":"200632438848897024","created_at":"2012-05-10T17:04:35.000Z","possibly_sensitive":false,"author_id":"556859372","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":90,"end":110,"url":"http://t.co/MbDQjK5q","expanded_url":"http://instagr.am/p/Ka6kVvuPX3/","display_url":"instagr.am/p/Ka6kVvuPX3/"}],"annotations":[{"start":10,"end":25,"probability":0.8728,"type":"Person","normalized_text":"Prof. Guido Rasi"},{"start":83,"end":88,"probability":0.9969,"type":"Place","normalized_text":"Poland"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Greatly appreciated, and many thanks for this round of upgrades. Far beyond FDA's website in terms of usability.","conversation_id":"200585243068088320","source":"Twitter Web Client","id":"200585570844545025","created_at":"2012-05-10T13:58:21.000Z","possibly_sensitive":false,"author_id":"73774967","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":[{"start":86,"end":88,"probability":0.7666,"type":"Organization","normalized_text":"FDA"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"200585243068088320"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Suggestion for filtering \"What's New?\" Page: Make one option \"Everything but EPARs\".","conversation_id":"200541232559161344","source":"Twitter Web Client","id":"200547882414260224","created_at":"2012-05-10T11:28:35.000Z","possibly_sensitive":false,"author_id":"73774967","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"200541232559161344"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Prof. Guido Rasi Executive Director of EMA has just started his visit in Poland","conversation_id":"200543654107021312","source":"Twitter for iPhone","id":"200543654107021312","created_at":"2012-05-10T11:11:47.000Z","possibly_sensitive":false,"author_id":"556859372","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":[{"start":10,"end":25,"probability":0.8722,"type":"Person","normalized_text":"Prof. Guido Rasi"},{"start":83,"end":88,"probability":0.9918,"type":"Place","normalized_text":"Poland"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News im looking for the time from submission to launch at EMA level. Any source/official information? Thks.","conversation_id":"196879292360179713","source":"Twitter for iPhone","id":"196879292360179713","created_at":"2012-04-30T08:30:55.000Z","possibly_sensitive":false,"author_id":"368277484","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"Looking forward to the release of the web based gateway later this year - https://t.co/Rtiv8zBM @EMA_News","conversation_id":"194359663343570944","source":"Twitter for iPad","id":"194407650052669440","created_at":"2012-04-23T12:49:30.000Z","possibly_sensitive":false,"author_id":"126271779","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":96,"end":105,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":74,"end":95,"url":"https://t.co/Rtiv8zBM","expanded_url":"https://twitter.com/ema_news/status/194359663343570944","display_url":"twitter.com/ema_news/statu…"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":2,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"quoted","id":"194359663343570944"},{"type":"replied_to","id":"194359663343570944"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"fr","text":"@EMA_News: eSubmission Gateway http://t.co/ibxJN2hQ les #AMM vont être délivrées plus vite. Leur respect on s'en fout toujours. #Risperdal","conversation_id":"194390912019857408","source":"Twitter for Android","id":"194390912019857408","created_at":"2012-04-23T11:42:59.000Z","possibly_sensitive":false,"author_id":"498737720","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":56,"end":60,"tag":"AMM"},{"start":128,"end":138,"tag":"Risperdal"}],"urls":[{"start":31,"end":51,"url":"http://t.co/ibxJN2hQ","expanded_url":"http://bit.ly/HZOQQg","display_url":"bit.ly/HZOQQg"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"es","text":"@EMA_News Greetings from @ResortCostabaja La Paz Mexico, Sea of Cortez.","conversation_id":"193328104725413889","source":"Twitter for BlackBerry®","id":"193335209758953472","created_at":"2012-04-20T13:48:00.000Z","possibly_sensitive":false,"author_id":"371831444","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":25,"end":41,"username":"ResortCostabaja","id":"319268855"}],"hashtags":{},"urls":{},"annotations":[{"start":42,"end":54,"probability":0.2245,"type":"Place","normalized_text":"La Paz Mexico"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"193328104725413889"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Thank you for the RT! :-)  Hope you have a great weekend!","conversation_id":"193263064450203648","source":"Hootsuite","id":"193263064450203648","created_at":"2012-04-20T09:01:19.000Z","possibly_sensitive":false,"author_id":"76913784","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News thanks!","conversation_id":"192243970498236416","source":"Twitter for BlackBerry®","id":"192547409572798464","created_at":"2012-04-18T09:37:34.000Z","possibly_sensitive":false,"author_id":"23872146","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"192243970498236416"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News how do we register a topical analgesic from the Philippines? should we go to London or do you have a satellite ofc in asia? thanks","conversation_id":"192243266551427074","source":"Twitter Web Client","id":"192243266551427074","created_at":"2012-04-17T13:29:01.000Z","possibly_sensitive":false,"author_id":"23872146","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":[{"start":58,"end":68,"probability":0.9461,"type":"Place","normalized_text":"Philippines"},{"start":87,"end":92,"probability":0.9887,"type":"Place","normalized_text":"London"},{"start":128,"end":131,"probability":0.806,"type":"Place","normalized_text":"asia"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News published new document on regulatory procedural advice on biosimilar medicines http://t.co/MSkJKIqD","conversation_id":"190177540256698368","source":"Hootsuite","id":"190177540256698368","created_at":"2012-04-11T20:40:33.000Z","possibly_sensitive":false,"author_id":"35566529","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":89,"end":109,"url":"http://t.co/MSkJKIqD","expanded_url":"http://bit.ly/HrSxPI","display_url":"bit.ly/HrSxPI"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Is there a new April list for CHMP drugs under review?","conversation_id":"175336211462881282","source":"Twitter for BlackBerry®","id":"189358563116855297","created_at":"2012-04-09T14:26:14.000Z","possibly_sensitive":false,"author_id":"267894360","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"175336211462881282"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Thanks for RT! #WDDgoblue","conversation_id":"187469768167661568","source":"Twitter Web Client","id":"187469768167661568","created_at":"2012-04-04T09:20:50.000Z","possibly_sensitive":false,"author_id":"15179874","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":25,"end":35,"tag":"WDDgoblue"}],"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"RT @EMA_News: EU Clin. Trials Register info now available through WHO’s Intern. Clin. Trials Registry Platform http://t.co/O73ahj9v","conversation_id":"184271031672897536","source":"TweetDeck","id":"184550331064135681","created_at":"2012-03-27T08:00:02.000Z","possibly_sensitive":false,"author_id":"125985779","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":3,"end":12,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":111,"end":131,"url":"http://t.co/O73ahj9v","expanded_url":"http://bit.ly/GQBGu5","display_url":"bit.ly/GQBGu5"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"184271031672897536"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News published the strain recommendations for 2012/2013 seasonal flu vaccines: http://t.co/0StmDiVt","conversation_id":"182048863249641472","source":"TweetDeck","id":"182048863249641472","created_at":"2012-03-20T10:20:05.000Z","possibly_sensitive":false,"author_id":"204752573","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":84,"end":104,"url":"http://t.co/0StmDiVt","expanded_url":"http://bit.ly/FPlH7Y","display_url":"bit.ly/FPlH7Y"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News When will the CHMP reviews be published online? My understanding was March 1.","conversation_id":"174895610959364096","source":"Twitter for BlackBerry®","id":"175253761432879104","created_at":"2012-03-01T16:18:47.000Z","possibly_sensitive":false,"author_id":"267894360","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"174895610959364096"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Hi. I'm searching on ur website for info (i.e. SPC) of the product EXCENEL RTU. Do u know where can i find that info? Thx!","conversation_id":"174527363307151360","source":"TweetDeck","id":"174527363307151360","created_at":"2012-02-28T16:12:20.000Z","possibly_sensitive":false,"author_id":"31437646","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"Probably going to get a large number of responses to these with all eyes on the Pharmacovigilance legislation this year.  @EMA_News","conversation_id":"172300899945938944","source":"Twitter Web Client","id":"173157028385128448","created_at":"2012-02-24T21:27:07.000Z","possibly_sensitive":false,"author_id":"126271779","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":122,"end":131,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":[{"start":80,"end":96,"probability":0.417,"type":"Organization","normalized_text":"Pharmacovigilance"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"172300899945938944"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"GlaxoSmithKline decides not to extend indication for lapatinib for use in HER2+ metastatic breast cancer (via @EMA_News) #GSK #Tyverb","conversation_id":"170148477295267843","source":"Twitter Web Client","id":"170154312721367040","created_at":"2012-02-16T14:35:24.000Z","possibly_sensitive":false,"author_id":"312830580","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":110,"end":119,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":121,"end":125,"tag":"GSK"},{"start":126,"end":133,"tag":"Tyverb"}],"urls":{},"annotations":[{"start":0,"end":14,"probability":0.5705,"type":"Organization","normalized_text":"GlaxoSmithKline"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"170148477295267843"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News: European Medicines Agency and European Commission extend confidentiality arrangement with Japan: http://t.co/10Cu5fGb","conversation_id":"169455816238313473","source":"Twitter for iPhone","id":"169455816238313473","created_at":"2012-02-14T16:19:49.000Z","possibly_sensitive":false,"author_id":"200109222","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":108,"end":128,"url":"http://t.co/10Cu5fGb","expanded_url":"http://bit.ly/wQXA8Q","display_url":"bit.ly/wQXA8Q"}],"annotations":[{"start":11,"end":35,"probability":0.4765,"type":"Organization","normalized_text":"European Medicines Agency"},{"start":101,"end":105,"probability":0.8309,"type":"Place","normalized_text":"Japan"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News is reviewing #Gilenya (fingolimod) following concerns about #CVD risks. Read http://t.co/hgyLgwXx for further info. #patients","conversation_id":"160340246960156672","source":"Twitter Web Client","id":"160340246960156672","created_at":"2012-01-20T12:37:48.000Z","possibly_sensitive":false,"author_id":"407008173","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":23,"end":31,"tag":"Gilenya"},{"start":70,"end":74,"tag":"CVD"},{"start":126,"end":135,"tag":"patients"}],"urls":[{"start":87,"end":107,"url":"http://t.co/hgyLgwXx","expanded_url":"http://bit.ly/AbZkqU","display_url":"bit.ly/AbZkqU"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News - EMA will set up a network to work with #healthcare professionals","conversation_id":"154124604913364992","source":"Twitter Web Client","id":"154124604913364992","created_at":"2012-01-03T08:59:03.000Z","possibly_sensitive":false,"author_id":"216314816","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":51,"end":62,"tag":"healthcare"}],"urls":{},"annotations":[{"start":12,"end":14,"probability":0.345,"type":"Organization","normalized_text":"EMA"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News: EMA gives interim recommendations to deal with shortcomings in quality assurance at #Ben_Venue_Laboratories http://t.co/REkwT66f","conversation_id":"140187756558163969","source":"Twitter for Android","id":"140187756558163969","created_at":"2011-11-25T21:59:00.000Z","possibly_sensitive":false,"author_id":"189902514","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":95,"end":118,"tag":"Ben_Venue_Laboratories"}],"urls":[{"start":119,"end":139,"url":"http://t.co/REkwT66f","expanded_url":"http://bit.ly/sLzVet","display_url":"bit.ly/sLzVet"}],"annotations":[{"start":11,"end":13,"probability":0.4445,"type":"Organization","normalized_text":"EMA"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News \"The 14th annual congress of the European Society for Sexual Medicine\", Dec 1-4, Italy, More: http://t.co/YtTTVgad #essm #essm11","conversation_id":"136856670298054656","source":"Twitter Web Client","id":"136856670298054656","created_at":"2011-11-16T17:22:27.000Z","possibly_sensitive":false,"author_id":"32860247","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":125,"end":130,"tag":"essm"},{"start":131,"end":138,"tag":"essm11"}],"urls":[{"start":104,"end":124,"url":"http://t.co/YtTTVgad","expanded_url":"http://bit.ly/tLTHP8","display_url":"bit.ly/tLTHP8"}],"annotations":[{"start":43,"end":78,"probability":0.364,"type":"Other","normalized_text":"European Society for Sexual Medicine"},{"start":91,"end":95,"probability":0.6712,"type":"Place","normalized_text":"Italy"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News I am following you on twitter and I think you would “like” our Facebook page:  http://t.co/aigLPypl","conversation_id":"118395611497234433","source":"Twitter Web Client","id":"118395611497234433","created_at":"2011-09-26T18:44:48.000Z","possibly_sensitive":false,"author_id":"91397556","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":[{"start":89,"end":109,"url":"http://t.co/aigLPypl","expanded_url":"http://bit.ly/bjisQb","display_url":"bit.ly/bjisQb"}],"annotations":[{"start":32,"end":38,"probability":0.7779,"type":"Product","normalized_text":"twitter"},{"start":73,"end":80,"probability":0.6408,"type":"Product","normalized_text":"Facebook"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News publish #inspection procedures this week: useful for those of us being inspected too. http://t.co/x2eAc7N","conversation_id":"99407404982222848","source":"Twitter Web Client","id":"99407404982222848","created_at":"2011-08-05T09:12:26.000Z","possibly_sensitive":false,"author_id":"339094072","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":18,"end":29,"tag":"inspection"}],"urls":[{"start":96,"end":115,"url":"http://t.co/x2eAc7N","expanded_url":"http://tinyurl.com/3u8rvrn","display_url":"tinyurl.com/3u8rvrn"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_news Plans Public Access to Side-Effects Data. Find more @BioPharmIntl: http://t.co/EKRttVD #bio #pharma #biopharm","conversation_id":"95458578697170944","source":"Twitter for Websites","id":"95458578697170944","created_at":"2011-07-25T11:41:13.000Z","possibly_sensitive":false,"author_id":"285218908","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"},{"start":62,"end":75,"username":"BioPharmIntl","id":"263819136"}],"hashtags":[{"start":97,"end":101,"tag":"bio"},{"start":102,"end":109,"tag":"pharma"},{"start":110,"end":119,"tag":"biopharm"}],"urls":[{"start":77,"end":96,"url":"http://t.co/EKRttVD","expanded_url":"http://bit.ly/qjLq4R","display_url":"bit.ly/qjLq4R"}],"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"fr","text":"@EMA_News : celecoxib accepté pour la polypose adenomateuse familiale. http://bit.ly/mRTMnd","conversation_id":"71542366393204736","source":"Twitter Web Client","id":"71542366393204736","created_at":"2011-05-20T11:46:43.000Z","possibly_sensitive":false,"author_id":"216838030","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News: your link wrt Pandemrix, narcolepy seems not to work","conversation_id":"38555028419514368","source":"TweetDeck","id":"38560502737014784","created_at":"2011-02-18T11:28:34.000Z","possibly_sensitive":false,"author_id":"118116598","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":[{"type":"replied_to","id":"38555028419514368"}],"geo":{"coordinates":{"coordinates":{}}}},{"lang":"pt","text":"@EMA_News RT #FF \" vou guardar seu lugar embaixo do meu guarda sol\"  http://www.youtube.com/watch?v=ta2KUkrZViI","conversation_id":"27352683045","source":"Twitter Web Client","id":"27352683045","created_at":"2010-10-14T15:44:28.000Z","possibly_sensitive":false,"author_id":"171871646","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":13,"end":16,"tag":"FF"}],"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Pl forward yr friends t help me more as u can\nPl support my study & appeal http://www.petitiononline.com/21121989/petition.html","conversation_id":"13500897133","source":"Twitter Web Client","id":"13500897133","created_at":"2010-05-06T18:15:37.000Z","possibly_sensitive":false,"author_id":"122005053","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@ema_news \nPlease support my study and appeal: http://www.petitiononline.com/21121989/petition.html","conversation_id":"13390094600","source":"Twitter Web Client","id":"13390094600","created_at":"2010-05-04T23:14:18.000Z","possibly_sensitive":false,"author_id":"122005053","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":{},"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@ema_news All strange things are around me in my key stages both in UK and China\nhttp://96mfpbloodshedincident.blogspot.com/","conversation_id":"13390068245","source":"Twitter Web Client","id":"13390068245","created_at":"2010-05-04T23:13:43.000Z","possibly_sensitive":false,"author_id":"122005053","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":[{"start":68,"end":69,"probability":0.9882,"type":"Place","normalized_text":"UK"},{"start":75,"end":79,"probability":0.9351,"type":"Place","normalized_text":"China"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}},{"lang":"en","text":"@EMA_News Pl sees post barcode posted to Obama\nhttp://www.facebook.com/WhiteHouse?ref=ts#!/topic.php?uid=63811549237&topic=19228","conversation_id":"13390055986","source":"Twitter Web Client","id":"13390055986","created_at":"2010-05-04T23:13:26.000Z","possibly_sensitive":false,"author_id":"122005053","in_reply_to_user_id":"116716199","entities":{"mentions":[{"start":0,"end":9,"username":"EMA_News","id":"116716199"}],"hashtags":{},"urls":{},"annotations":[{"start":41,"end":45,"probability":0.9754,"type":"Person","normalized_text":"Obama"}],"cashtags":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"referenced_tweets":{},"geo":{"coordinates":{"coordinates":{}}}}]
